Please use this identifier to cite or link to this item:
https://rima.ufrrj.br/jspui/handle/20.500.14407/11821
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Santana, Raissa Couto | |
dc.date.accessioned | 2023-12-22T01:57:29Z | - |
dc.date.available | 2023-12-22T01:57:29Z | - |
dc.date.issued | 2019-02-25 | |
dc.identifier.citation | SANTANA, Raissa Couto. Avaliação do potencial microbicida dos compostos 1,8-cineol, alfa-pineno e p-cimeno presentes em óleos essenciais do gênero Protium sobre Leishmania amazonensis in vitro. 2019. 77 f. Dissertação. (Mestrado em Ciências Veterinárias) - Instituto de Veterinária, Universidade Federal do Rio de Janeiro, Seropédica, 2019. | por |
dc.identifier.uri | https://rima.ufrrj.br/jspui/handle/20.500.14407/11821 | - |
dc.description.abstract | As leishmanioses se encontram entre as mais importantes no grupo das doenças negligenciadas. Segundo dados da OMS, o número de casos pode chegar a 1,3 milhão anualmente. As manifestações clínicas destas doenças, afligem humanos e animais, sendo um problema de saúde pública e veterinária. Os fármacos utilizados no tratamento possuem vários problemas como administração dificultosa, alta toxicidade, custo elevado e além disso, casos de resistência tem sido reportados. Os óleos essenciais são metabólitos secundários produzidos pelas plantas constituídos por uma complexa mistura de diferentes substâncias. Neste trabalho estudamos o potencial microbicida dos compostos 1,8-cineol, p-cimeno e αpineno presentes em óleos essencias do gênero Protium sobre o parasito Leishmania amazonensis um dos agentes etiológicos da leishmaniose cutânea e difusa cutânea no Novo Mundo, in vitro. Nossos dados mostraram que o tratamento com os compostos 1,8-cineol, αpineno e p-cimeno dos macrófagos murinos infectados com formas promastigotas de L. amazonensis possui atividade anti-amastigota. Os compostos inibiram a sobrevivência dos amastigotas de forma concentração dependente, com IC50 de 40 μg/mL, 50,1 μg/mL e 41,4 μg/mL para α-pineno, p-cimeno e 1,8-cineol, respectivamente. A avaliação da citotoxicidade para os macrófagos murinos foi avaliada por XTT e os resultados mostraram que as células permaneceram viáveis entre 70-95 % até a concentração mais alta testada (200μg/mL), assim como sua capacidade fagocítica não foi alterada pelo tratamento. A produção de óxido nítrico por macrófagos foi analisada por ser uma molécula altamente tóxica para microorganimos intracelulares, no entanto, o tratamento de macrófagos estimulados ou não com LPS, mostrou que estes compostos não modulam a produção de NO pelos macrófagos. Outro possível mecanismo de ação avaliado foi o efeito na composição lipídica dos parasitos tratados, nossos resultados mostraram que promastigotas de L. amazonensis apresentaram uma mudança no perfil lipídico após 48h de tratamento na concentração de 50 µg/mL dos compostos. O tratamento com 1,8-cineol diminuiu as concentrações de triacilglicerol e esterol + 1.2 diacilglicerol em torno de 50%, enquanto que em ácidos graxos e 1.3 diacilglicerol há uma tendência de redução nos parasitos tratados. Por outro lado, α-pineno aumentou as concentrações de triacilglicerol e esterol esterificado em 50% e p-cimeno aumentou em 26% de triacilglicerol. Os resultados indicam que os compostos α-pineno, p-cimeno e 1,8-cineol tem atividade anti-Leishmania contra Leishmania amazonensis. | por |
dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | por |
dc.format | application/pdf | * |
dc.language | por | por |
dc.publisher | Universidade Federal Rural do Rio de Janeiro | por |
dc.rights | Acesso Aberto | por |
dc.subject | Leishmania amazonensis | por |
dc.subject | Terpenos | por |
dc.subject | Protium | por |
dc.subject | Tratamentos | por |
dc.subject | Leishmania amazonensis | eng |
dc.subject | Terpenes | eng |
dc.subject | Protium | eng |
dc.subject | Treatment | eng |
dc.title | Avaliação do potencial microbicida dos compostos 1,8-cineol, alfa-pineno e p-cimeno presentes em óleos essenciais do gênero Protium sobre Leishmania amazonensis in vitro | por |
dc.title.alternative | Microbicidal potential evaluation of 1,8-cineole, α-pinene and p-cymene compounds of essential oil from Protium genus on Leishmania amazonensis in vitro | eng |
dc.type | Dissertação | por |
dc.description.abstractOther | Leishmaniases are one of the wide neglected diseases in the world. According to WHO, the number of cases can reach 1.3 million year. The clinical manifestations of these diseases affect humans and animals, being a public and veterinary health problem. The current treatment presents several problems such as difficult of administration, high toxicity and highcosts; besides drug-resistance being observed in many cases. Essential oils are secondary metabolites synthesized by plants, composed of a complex mixture of different substances. In this work, we study in vitro the microbicide potential of 1,8-cineole, p-cymene and α-pinene compounds present in essential oils of Protium genus on Leishmania amazonensis, one of the etiological agents of cutaneous and diffuse cutaneous leishmaniasis in the New World. Our data showed that treatment of L. amazonensis infected macrophages with the compounds 1,8- cineole, α-pinene and p-cymene have an anti-amastigote activity. The compounds inhibited the amastigotes survival in a concentration-dependent manner with IC50 of 40 μg/mL, 50,1 μg/mL and 41,4 μg/mL for α-pinene, p-cymene and 1,8-cineole, respectively. The cytotoxicity for murine macrophages was evaluated by XTT and the results showed that the cells viability remained among 70-95% up to the highest tested concentration (200μg / mL), as well as, their phagocytic capacity was not altered by treatment. Nitric oxide production by macrophages was analyzed because it is a highly toxic molecule for intracellular microorganisms, however, the treatment of resting or LPS-activated macrophages did not modulate NO production by macrophages. Another possible mechanism of action analyzed was the effect of treatment on parasite lipid composition, our results showed that treated L. amazonensis promastigotes had a change in the lipid profile after 48h of treatment at 50 μg/mL of the compounds. 1,8-cineole treatment decreases around 50% the concentrations of triacylglycerol and sterol + 1.2-diacylglycerol, whereas in fatty acids and 1,3-diacylglycerol there is a tendency of reduction on treated parasites. On the other hand, α-pinene increased the concentrations of triacylglycerol and sterol sterified by 50% and p-cymene augmented 26% of tryacylglycerol. The results indicate that α-pinene, p-cymene and 1,8-cineol compounds have anti-Leishmania activity against Leishmania amazonensis. | eng |
dc.contributor.advisor1 | Silva, Lucia Helena Pinto da | |
dc.contributor.advisor1ID | https://orcid.org/0000-0002-7085-8649 | por |
dc.contributor.advisor1ID | 037.500.287-10 | por |
dc.contributor.advisor1Lattes | http://lattes.cnpq.br/0013386072339397 | por |
dc.contributor.referee1 | Silva, Lucia Helena Pinto da | |
dc.contributor.referee1ID | https://orcid.org/0000-0002-7085-8649 | por |
dc.contributor.referee1ID | 037.500.287-10 | por |
dc.contributor.referee1Lattes | http://lattes.cnpq.br/0013386072339397 | por |
dc.contributor.referee2 | Rodrigues, Juliany Cola Fernandes | |
dc.contributor.referee2ID | https://orcid.org/0000-0001-6807-8101 | por |
dc.contributor.referee2Lattes | http://lattes.cnpq.br/6200651359121160 | por |
dc.contributor.referee3 | Graebin, Cedric Stephan | |
dc.contributor.referee3ID | https://orcid.org/0000-0003-1410-1227 | por |
dc.contributor.referee3Lattes | http://lattes.cnpq.br/4900857097448760 | por |
dc.contributor.referee4 | Soares, Deivid Costa | |
dc.contributor.referee4Lattes | http://lattes.cnpq.br/7894147147292742 | por |
dc.contributor.referee5 | Lima, Patrícia Fampa Negreiros | |
dc.contributor.referee5ID | https://orcid.org/0000-0003-3440-1622 | por |
dc.contributor.referee5Lattes | http://lattes.cnpq.br/8327606827760440 | por |
dc.creator.ID | https://orcid.org/0000-0001-5883-3783 | por |
dc.creator.ID | 28.646.699-0 | por |
dc.creator.ID | 156.694647-61 | por |
dc.creator.Lattes | http://lattes.cnpq.br/2711105842691744 | por |
dc.publisher.country | Brasil | por |
dc.publisher.department | Instituto de Veterinária | por |
dc.publisher.initials | UFRRJ | por |
dc.publisher.program | Programa de Pós-Graduação em Ciências Veterinárias | por |
dc.relation.references | ABBASI, I., DE QUEIROZ, A. T. L., KIRSTEIN, O. D., NASEREDDIN, A., HORWITZ, B. Z., HAILU, A., SALAH, I., MOTA, T.F., FRAGA, D. B. M., VERAS, P. S. T., POCHE, D., POCHE, R., YESZHANOV, A, TORRES-POCHE, C. B. Z., WARBURG, A. Plantfeeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa. Proceedings of the National Academy of Sciences, v. 115, n. 46, p. 11790-11795, 2018. ABDELADHIM, M., KAMHAWI, S., VALENZUELA, J. G. What’s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infection, Genetics and Evolution, v. 28, p. 691-703, 2014. ABDOLRAHIMZADEH, H., BOLANDPARVAZ, S., ABBASI, H. R., DEHGHANKHALILI, M., PAYDAR, S., DEHGHANIAN, A., ZARE, M. Antimicrobial Survey of Local Herbal Drugs against Acinetobacter baumannii Isolated from Patients Admitted to a Level-I Trauma Center. Bulletin of Emergency & Trauma, v. 6, n.4, p.355, 2018. ABEBE, T., HAILU, A., WOLDEYES, M., MEKONEN, W., BILCHA, K.; CLOKE, T., FRY, L., SEICH AL BASATENA, N.K., CORWARE, K., MODOLELL, M. Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia. PLoS neglected tropical diseases, v. 6, n. 6, p. e1684, 2012. ACADEMIA BRASILEIRA DE CIÊNCIAS (ABC). Doenças Negligenciadas. Disponível em: http://www.abc.org.br/atuacao/nacional/grupos-de-estudos/doencas-negligenciadas/. Acesso em 09 de Março de 2019. ADLER-MOORE, J., PROFFITT, R. T. AmBisome: Lipsomal formulation, structure, mechanism of action and pre-clinical experience. Journal of Antimicrobial Chemotherapy, v. 49, n. 1, p. 21-30, 2002 ALINA C.-M.C., ROCÍO R.-L., AURELIO R.-M.M., MARGARITA C.-M.M., ANGÉLICA R.-G., RUBÉN J.-A. Chemical Composition and In vivo Anti-inflammatory Activity of Bursera morelensis Ramírez Essential Oil. J. Essent. Oil Bear. Plants. v. 17, p. 758–768, 2014; ALLMANN, S., MAZET, M., ZIEBART, N., BOUYSSOU, G., FOUILLEN, L., DUPUY, J. W., ... & BOSHART, M. Triacylglycerol storage in lipid droplets in procyclic trypanosoma brucei. PLoS One, v. 9, n. 12, p. e114628, 2014. ALVAR, J., VELEZ, I. D., BERN, C., HERRERO, M., DESJEUX, P., CANO, J., JANNIN, J., MARGRIET DEN BOER, M. Leishmaniasis worldwide and global estimates of its incidence. PloS one, v. 7, n. 5, p. e35671, 2012. AMARAL, M. P., BRAGA, F. A., PASSOS, F. F., ALMEIDA, F. R., OLIVEIRA, R. C., CARVALHO, A. A., OLIVEIRA, F. A. Additional evidence for the anti-inflammatory properties of the essential oil of Protium heptaphyllum resin in mice and rats. Lat Am J Pharm, v. 28, p. 775-782, 2009. AMATO, V. S., TUON, F. F., BACHA, H. A., NETO, V. A., NICODEMO, A. C. Mucosal leishmaniasis. Mucosal leishmaniasis: current scenario and prospects for treatment. Acta tropica, v. 105, n. 1, p. 1-9, 2008. AMATO, V. S., TUON, F. F., IMAMURA, R., ABEGAO DE CAMARGO, R., DUARTE, M. I., & NETO, V. A. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil. Journal of the European Academy of Dermatology and Venereology, v. 23, n. 9, p. 1026-1034, 2009. AMATO, V., AMATO, J., NICODEMO, A., UIP, D., AMATO-NETO, V., & DUARTE, M. (1998, August). Treatment of mucocutaneous leishmaniasis with pentamidine isothionate. In Annales de Dermatologie et de Venereologie (Vol. 125, No. 8, pp. 492-495). ANDRADE, H. M. TOLEDO, V. P. C. P., PINHEIRO, M. B., GUIMARÃES, T. M. P. D., OLIVEIRA, N. C., CASTRO, J. A., SILVA, A. S. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (= L. chagasi) in Brazil. Veterinary parasitology, v. 181, n. 2-4, p. 83-90, 2011. ANDRADE-OCHOA S, NEVÁREZ-MOORILLÓN GV, SÁNCHEZ-TORRES LE, VILLANUEVA-GARCÍA M, SÁNCHEZ-RAMÍREZ BE, RODRÍGUEZ-VALDEZ LM, RIVERA-CHAVIRA B. E. Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis. BMC Complement Altern Med. v. 23, n .15, p. 332, 2015 ARAUJO D.A.O.V., TAKAYAMA C., DE-FARIA F.M., SOCCA E.A.R., DUNDER R.J., MANZO L.P., LUIZ-FERREIRA A., SOUZA-BRITO A.R.M. Potium heptaphyllum on experimental gastric ulcer models in rats. Revista Brasileira de Farmacognosia, v. 21, n. 4, p. 721-729, 2011. AREVALO, I., TULLIANO, G., QUISPE, A., SPAETH, G., MATLASHEWSKI, G., LLANOS-CUENTAS, A., & POLLACK, H. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clinical Infectious Diseases, v. 44, n. 12, p. 1549-1554, 2007 AREVALO, I., WARD, B., MILLER, R., MENG, T. C., NAJAR, E., ALVAREZ, E., ALEJANDRO, L. C. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clinical infectious diseases, v. 33, n. 11, p. 1847-1851, 2001. ASBAGHIAN S., SHAFAGHAT A., ZAREA K., KASIMOV F., SALIMI F. Comparison of volatile constituents, and antioxidant and antibacterial activities of the essential oils of Thymus caucasicus, T. kotschyanus and T. vulgaris. Nat. Prod. Commun, v.6, p. 137–140, 2011. ASTANI, A., REICHLING, J., SCHNITZLER, P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, v. 24, n. 5, p. 673-679, 2010. ASTE, N. et al. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate. British Journal of Dermatology, v. 138, n. 2, p. 370-371, 1998. BACELLAR, O., LESSA, H., SCHRIEFER, A., MACHADO, P., RIBEIRO DE JESUS, A., DUTRA, W. O., GOLLOB, K. J., CARVALHO, E. M. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infection and immunity, v. 70, n. 12, p. 6734- 6740, 2002. 52 BALAÑA-FOUCE, R., REGUERA, R.M., CUBRÍA, J.C., ORDÓÑEZ, D. The pharmacology of leishmaniasis. Gen. Pharmacol. v. 30, n. 4, p. 435-443, 1998. BALASEGARAM, M., RITMEIJER, K., LIMA, M. A., BURZA, S., ORTIZ GENOVESE, G., MILANI, B., CHAPPUIS, F. Liposomal amphotericin B as a treatment for human leishmaniasis. Expert opinion on emerging drugs, v. 17, n. 4, p. 493-510, 2012. BARBOSA, M.A., ALEXANDRE-PIRES, G., SOARES-CLEMENTE, M., MARQUES, C., RODRIGUES, O.R., DE BRITO, T.V., DA FONSECA, I.P., ALVES, L.C., SANTOSGOMES, G.M. Cytokine gene expression in the tissues of dogs infected by Leishmania infantum. Journal of comparative pathology, v. 145, n. 4, p. 336-344, 2011. BASSELIN, M., COOMBS, G. H., BARRETT, M. P. Putrescine and spermidine transport in Leishmania. Molecular and biochemical parasitology, v. 109, n. 1, p. 37-46, 2000. BATES, P. A. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. International journal for parasitology, v. 37, n. 10, p. 1097-1106, 2007. BATES, P. A., ROGERS, M. E. New insights into the developmental biology and transmission mechanisms of Leishmania. Current molecular medicine, v. 4, n. 6, p. 601- 609, 2004 BENNETT, J. E.; DOLIN, R.; BLASER, M. J. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases E-Book. Elsevier Health Sciences, 2014. BEST, M. P., ASH, A., BERGFELD, J., BARRETT, J. The diagnosis and management of a case of leishmaniosis in a dog imported to Australia. Veterinary parasitology, v. 202, n. 3-4, p. 292-295, 2014. BLOWMAN, K., MAGALHÃES, M., LEMOS, M. F. L., CABRAL, C., PIRES, I. M. Anticancer Properties of Essential Oils and Other Natural Products. Evidence-Based Complementary and Alternative Medicine, v. 2018, 2018. BONJARDIM L. R. , CUNHA E. S, GUIMARÃES A. G, SANTANA M. F, OLIVEIRA M. G, SERAFINI M. R, ARAÚJO A. A, ANTONIOLLI A. R, CAVALCANTI S. C, SANTOS M. R, QUINTANS-JÚNIOR L. J. Evaluation of the anti-inflammatory and antinociceptive properties of p-cymene in mice. Z. Caturforsch C. v. 67, n. 1-2, p. 15-21, 2012. BOUZENNA, H., HFAIEDH, N., GIROUX-METGES, M. A., ELFEKI, A., & TALARMIN, H. Potential protective effects of alpha-pinene against cytotoxicity caused by aspirin in the IEC-6 cells. Biomedicine & Pharmacotherapy, v. 93, p. 961-968, 2017 BRUCHHAGE, K. L., KOENNECKE, M., DRENCKHAN, M., PLÖTZE-MARTIN, K., PRIES, R., WOLLENBERG, B. 1, 8-cineol inhibits the Wnt/β-catenin signaling pathway through GSK-3 dephosphorylation in nasal polyps of chronic rhinosinusitis patients. European journal of pharmacology, v. 835, p. 140-146, 2018. BUATES, S., MATLASHEWSKI, G. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. The Journal of infectious diseases, v. 179, n. 6, p. 1485-1494, 1999. BURZA, S., CROFT, S. L., BOELAERT, M. Leishmaniasis. The Lancet, v. 15, n. 392(10151), p. 951-970, 2018. BURZA, S., MAHAJAN, R., SANZ, M. G., SUNYOTO, T., KUMAR, R., MITRA, G., & LIMA, M. A. HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination. Clinical Infectious Diseases, v. 59, n. 4, p. 552-555, 2014. BURZA, S., NABI, E., MAHAJAN, R., MITRA, G., LIMA M. A. One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India. Clinical infectious diseases, v. 57, n. 9, p. 1363-1364, 2013. CALVOPINA, M., GOMEZ, E. A., SINDERMANN, H., COOPER, P. J., HASHIGUCHI, Y. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. The American journal of tropical medicine and hygiene, v. 75, n. 6, p. 1074-1077, 2006. CARNEIRO DE FREITAS, J. C., SOUSA NUNES-PINHEIRO, D. C., & AMARAL DE ABREU, C. R. Geographical variation in clinical signs and prevalence of Leishmania sp. infection among dogs in Fortaleza, Ceará State, Brazil. Acta Scientiae Veterinariae, v.38, n. 3, 2010. CARRILLO, E., MORENO, J. Cytokine profiles in canine visceral leishmaniasis. Veterinary immunology and immunopathology, v. 128, n. 1-3, p. 67-70, 2009. CARVALHO, E. M., BARRAL, A., COSTA, J. M., BITTENCOURT, A., MARSDEN, P. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop, v. 56, p. 315–325, 1994. CARVALHO, E. M., BARRAL, A., PEDRAL-SAMPAIO, D., BARRAL-NETTO, M., BADARO, R., ROCHA, H., & JOHNSON JR, W. D. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. Journal of Infectious Diseases, v. 165, n. 3, p. 535-540, 1992. CASEY, A. L., KARPANEN, T. J., CONWAY, B. R., WORTHINGTON, T., NIGHTINGALE, P., WATERS, R., ELLIOTT, T. S. J. Enhanced chlorhexidine skin penetration with eucalyptus oil. BMC infectious diseases, v. 10, n. 1, p. 278, 2010. CASTELLANO, L. R., FILHO, D. C., ARGIRO, L., DESSEIN, H., PRATA, A., DESSEIN, A., RODRIGUES, V. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production. Human Immunology, v. 70, n. 6, p. 383-390, 2009. CASTELLUCCI, L., JAMIESON, S. E., ALMEIDA, L., OLIVEIRA, J., GUIMARAES, L. H., LESSA, M., FAKIOLA, M., JESUS, A. R., NANCY MILLER, E., CARVALHO, E. M., BLACKWELL, J. M. Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil. Infection, genetics and evolution, v. 12, n. 5, p. 1102-1110, 2012. CAVALIERO, T., ARNOLD, P., MATHIS, A., GLAUS, T., HOFMANN-LEHMANN, R., DEPLAZES, P., 1999. Clinical, serologic, and parasitologic follow‐up after long‐term allopurinol therapy of dogs naturally infected with Leishmania infantum. Journal of veterinary internal medicine, v. 13, n. 4, p. 330-334, 1999. CAYMAN CHEMICAL. SAFETY DATA SHEET. 2017/2018. Disponível em: https://www.caymanchem.com/msdss/23159m.pdf (p-cimeno), https://www.caymanchem.com/msdss/21576m.pdf (α-pineno), https://www.caymanchem.com/msdss/22183m.pdf (1,8-cineol). Acesso em 11 de Março de 2019. CENTRO DE CONTROLE E PREVENÇÃO DE DOENÇAS (CDC). Neglected Tropical Diseases. 2018. Disponível em: https://www.cdc.gov/globalhealth/ntd/diseases/index.html. Acesso em: 20 de Dezembro de 2018. CHARLAB, R., VALENZUELA, J. G., ROWTON, E. D., & RIBEIRO, J. M. Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis. Proceedings of the National Academy of Sciences, v. 96, n. 26, p. 15155-15160, 1999. CHAWLA, B., JHINGRAN, A., PANIGRAHI, A., STUART, K. D., MADHUBALA, R. Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin–susceptible–resistant Leishmania donovani. PloS one, v. 6, n. 10, p. e26660, 2011. CHEN, W., LIU, Y., LI, M., MAO, J., ZHANG, L., HUANG, R., YE, L. ANTI-tumor effect of α-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest. Journal of pharmacological sciences, v. 127, n. 3, p. 332-338, 2015. CHIU, C. C., KEELING, C. I., & BOHLMANN, J.Toxicity of pine monoterpenes to mountain pine beetle. Scientific reports, v. 7, n. 1, p. 8858, 2017. CIFTCI O, OZDEMIR I, TANYILDIZI S, YILDIZ S, OGUZTURK H. Antioxidative effects of curcumin, β-myrcene and 1, 8-cineole against 2, 3, 7, 8-tetrachlorodibenzo-p-dioxininduced oxidative stress in rats liver. Toxicol. Ind Health, v. 27, n. 5, p. 447-53, 2011. COLOMBO, F. A., ODORIZZI, R. M., LAURENTI, M. D., GALATI, E. A., CANAVEZ, F., PEREIRA-CHIOCCOLA, V. L. Detection of Leishmania (Leishmania) infantum RNA in fleas and ticks collected from naturally infected dogs. Parasitology research, v. 109, n. 2, p. 267-274, 2011. CORTÁZAR, T. M., COOMBS, G. H., WALKER, J. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine. Experimental parasitology, v. 116, n. 4, p. 475-482, 2007. COSTA, C. H. N. How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy. Revista da Sociedade Brasileira de Medicina Tropical, v. 44, n. 2, p. 232-242, 2011. COSTA, D. N. C. C., BERMUDI, P. M. M., RODAS, L. A. C., NUNES, C. M., HIRAMOTO, R. M., TOLEZANO, J. E., CIPRIANO R. S., CARDOSO G. C. D., CODEÇO C. T., NETO, F. C. Human visceral leishmaniasis and relationship with vector and canine control measures. Revista de saúde publica, v. 52, p. 92, 2018. COSTA, S., CAVADAS, C., CAVALEIRO, C., SALGUEIRO, L., DO CÉU SOUSA, M. In vitro susceptibility of Trypanosoma brucei brucei to selected essential oils and their major components. Experimental parasitology, v. 190, p. 34-40, 2018. COTRINA, J. F., INIESTA, V., MONROY, I., BAZ, V., HUGNET, C., MARAÑON, F., ALONSO, C. A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend® against canine leishmaniosis. Vaccine, v. 36, n. 15, p. 1972-1982, 2018. COURA, F. M., PASSOS, S. K. P., PELEGRINO, M. D. O. F., LEME, F. D. O. P., PAZ, G. F., GONTIJO, C. M. F., COSTA-VAL, A. P. D. Serological, molecular, and microscopic 55 detection of Leishmania in cats (Felis catus) in Belo Horizonte, Minas Gerais State, Brazil. Revista Brasileira de Parasitologia Veterinária, v. 27, n. 4, p. 570-574, 2018. COURA-VITAL, W., DE ALMEIDA LEAL, G. G., MARQUES, L. A., DA COSTA PINHEIRO, A., CARNEIRO, M., REIS, A. B. Effectiveness of deltamethrin-impregnated dog collars on the incidence of canine infection by Leishmania infantum: A large scale intervention study in an endemic area in Brazil. PloS one, v. 13, n. 12, p. e0208613, 2018. COURTENAY O., KOVACIC V., GOMES P. A., GARCEZ L. M., QUINNELL R. J. A long‐lasting topical deltamethrin treatment to protect dogs against visceral leishmaniasis. Medical and veterinary entomology, v. 23, n. 3, p. 245-256, 2009. CRAGG, G. M.; NEWMAN, D. J. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. v. 1830, n. 6, p. 3670–3695, 2014. CRISTANI M, D'ARRIGO M, MANDALARI G, CASTELLI F, SARPIETRO MG, MICIELI D, VENUTI V, BISIGNANO G, SAIJA A, TROMBETTA D J AGRIC. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. Food Chem, v. 55, n. 15, p. 6300-8, 2007. CROFT, S. L., OLLIARO, P. Leishmaniasis chemotherapy—challenges and opportunities. Clinical microbiology and infection, v. 17, n. 10, p. 1478-1483, 2011. CROFT, S. L., YARDLEY, V. Chemotherapy of leishmaniasis. Current pharmaceutical design, v. 8, n. 4, p. 319-342, 2002. DA FRANCA RODRIGUES, K. A., AMORIM, L. V., DIAS, C. N., MORAES, D. F. C., CARNEIRO, S. M. P., & DE AMORIM CARVALHO, F. A. Syzygium cumini (L.) Skeels essential oil and its major constituent α-pinene exhibit anti-Leishmania activity through immunomodulation in vitro. Journal of ethnopharmacology, v. 160, p. 32-40, 2015. DAMASCENO, M. D. B. M. V., SANTOS, S. A. A. R., BARBOSA, T. M., ARAÚJO, J. R. C., VIEIRA-NETO, A. E., WONG, D. V. T., CAMPOS, A. R. Acute and neuropathic orofacial antinociceptive effect of eucalyptol. Inflammopharmacology, v. 25, n. 2, p. 247- 254, 2017 DE GROOT, ANTON C.; SCHMIDT, ERICH. Essential oils, part III: chemical Composition. Dermatitis, v. 27, n. 4, p. 161-169, 2016. DE LIRA MOTA KS, DE OLIVEIRA PEREIRA F, DE OLIVEIRA WA, LIMA IO, DE OLIVEIRA LIMA E. Antifungal activity of Thymus vulgaris L. essential oil and its constituent phytochemicals against Rhizopus oryzae: interaction with ergosterol. Molecules. v. 17, n. 12, p. 14418-33, 2012. DE MACEDO-SILVA, S. T., URBINA, J. A., DE SOUZA, W., & RODRIGUES, J. C. F. In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis. PloS one, v. 8, n. 12, p. e83247, 2013. DE MENEZES, J. P. B., GUEDES, C. E. S., PETERSEN, A. L. D. O. A., FRAGA, D. B. M., VERAS, P. S. T. Advances in development of new treatment for leishmaniasis. BioMed research international, v. 2015, 2015. DE OLIVEIRA T. M, DE CARVALHO R. B, DA COSTA I. H, DE OLIVEIRA G. A, DE SOUZA A. A, DE LIMA S. G, DE FREITAS R. M. Evaluation of p-cymene, a natural antioxidant. Pharm Biol, v. 53, n. 3, p. 423-8, 2015 DE SANTANA, M. F. , GUIMARÃES A. G, CHAVES D. O, SILVA J. C, BONJARDIM L. R, DE LUCCA JÚNIOR W, FERRO J. N, BARRETO E. D. E. O, DOS SANTOS F. E, 56 SOARES M. B, VILLARREAL C. F, QUINTANS J. D. E S, QUINTANS-JÚNIOR L. J. The anti-hyperalgesic and anti-inflammatory profiles of p-cymene: Evidence for the involvement of opioid system and cytokines. Pharmaceutical biology, v. 53, n. 11, p. 1583-1590, 2015. DHAMA, K., CHAKRABORTY, S., KAPOOR, S., TIWARI, R., KUMAR, A., DEB, R., NATESAN, S. One world, one health-veterinary perspectives. Adv. Anim. Vet. Sci, v. 1, n. 1, p. 5-13, 2013. DI MATTIA, D., FONDEVILA, D., ABRAMO, F., FONDATI, A. A retrospective histopathological, immunohistochemical and molecular study of the presence of Leishmania spp. in the skin of cats with head and neck ulcerative dermatitis. Veterinary dermatology, v. 29, n. 3, p. 212-e76, 2018. DIAZ, N. L., ARVELÁEZ, F. A., ZERPA, O., & TAPIA, F. J. Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis. Clinical and Experimental Dermatology: Experimental dermatology, v. 31, n. 1, p. 114-117, 2006. DIRO, E., BLESSON, S., EDWARDS, T., RITMEIJER, K., FIKRE, H., ADMASSU, H., SOIPEI, P. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. PLoS neglected tropical diseases, v. 13, n. 1, p. e0006988, 2019. DIRO, E., RITMEIJER K, BOELAERT M, ALVES F, MOHAMMED R, ABONGOMERA C, RAVINETTO R, DE CROP M, FIKRE H, ADERA C, COLEBUNDERS R, VAN LOEN H, MENTEN J, LYNEN L, HAILU A AND VAN GRIENSVEN J. Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients, the first twelve months of a prospective cohort study. PLoS neglected tropical diseases, v. 9, n. 10, p. e0004087, 2015 DOGAN, G., KARA, N., BAGCI, E., & GUR, S. Chemical composition and biological activities of leaf and fruit essential oils from Eucalyptus camaldulensis. Zeitschrift für Naturforschung C, v. 72, n. 11-12, p.483-489, 2017. DOS ANJOS, J. L. V., DE SOUSA NETO, D., ALONSO, A. Effects of 1, 8-cineole on the dynamics of lipids and proteins of stratum corneum. International journal of pharmaceutics, v. 345, n. 1-2, p. 81-87, 2007. DOS SANTOS CAVALCANTI, A., ALVES, M. D. S., SILVA, L. C. P. D., PATROCÍNIO, D. D. S., SANCHES, M. N., CHAVES, D. S. D. A., & SOUZA, M. A. A. D. Volatiles composition and extraction kinetics from Schinus terebinthifolius and Schinus molle leaves and fruit. Revista Brasileira de Farmacognosia, v. 25, n. 4, p. 356-362, 2015. DOS SANTOS SALES, V., MONTEIRO, Á. B., DE ARAÚJO DELMONDES, G., DO NASCIMENTO, E. P. Antiparasitic Activity and Essential Oil Chemical Analysis of the Piper Tuberculatum Jacq Fruit. Iranian journal of pharmaceutical research: IJPR, v. 17, n. 1, p. 268, 2018. DYE, C. The logic of visceral leishmaniasis control. The American journal of tropical medicine and hygiene, v. 55, n. 2, p. 125-130, 1996 ECHCHAKERY, M., CHICHARRO, C., BOUSSAA, S., NIETO, J., CARRILLO, E., SHEILA, O., BOUMEZZOUGH, A.Molecular detection of Leishmania infantum and 57 Leishmania tropica in rodent species from endemic cutaneous leishmaniasis areas in Morocco. Parasites & vectors, v. 10, n. 1, p. 454, 2017. EDRIS, A. E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, v.21, n. 4, p. 308-323, 2007. EDWARDS, L. Imiquimod in clinical practice. Journal of the American Academy of Dermatology, v. 43, n. 1, p. S12-S17, 2000. EEDY, D. J. Imiquimod: a potential role in dermatology?. British Journal of Dermatology, v. 147, n. 1, p. 1-6, 2002. EL HASSAN, A. M., GHALIB, H. W., ZIJLSTRA, E. E., ELTOUM, I. A., SATTI, M., ALI, M. S., ALI, H. M. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 86, n. 3, p. 245-248, 1992 ELSHAFIE, HAZEM S.; CAMELE, IPPOLITO. An Overview of the Biological Effects of Some Mediterranean Essential Oils on Human Health. BioMed research international, v. 2017, 2017. ESCOBAR, P., MILENA LEAL, S., HERRERA, L. V., MARTINEZ, J. R., & STASHENKO, E. (2010). Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Memórias do Instituto Oswaldo Cruz, v. 105, n. 2, p. 184-190, 2010. EUROPEAN MEDICINES AGENCY LETIFEND (EMA). Summary of Product Characteristics. Disponível em: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_ Summary_for_the_public/veterinary/003865/WC500207742.pdf; 2017. Acesso em Janero de 2019. FERNANDES A. P., COSTA M. M., COELHO E. A., MICHALICK M. S., DE FREITAS E., MELO M. N., TAFURI W. L., RESENDE DDE M., HERMONT V., ABRANTES CDE F., GAZZINELLI R. T. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine, v. 26, n. 46, p. 5888-5895, 2008. FIROOZ, A., KHAMESIPOUR, A., GHOORCHI, M. H., NASSIRI-KASHANI, M., ESKANDARI, S. E., KHATAMI, A., DOWLATI, Y. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Archives of dermatology, v. 142, n. 12, p. 1575-1579, 2006. FOE F. M. C., NYEGUE M. A., KAMDEM S. L. S., ESSAMA R. H. S., ETOA F. Chemical composition, antioxidant effects and antimicrobial activities of some spices’ essential oils on food pathogenic bacteria. Afr. J. Biotechnol. V.15, p. 649–656, 2016. FOOD AND DRUG ADMINISTRATION. Substances Generally Recognized as Safe Food Additives Permitted for Direct Addition to Food for Human Consumption. C.F.R 2006. Disponível em https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=172.515.acess ado em 08 janeiro de 2018.FREITAS, J.C., NUNES-PINHEIRO, D.C., ABREU, C.R. Geographical variation in clinical signs and prevalence of Leishmania sp. infection among dogs in Fortaleza, Ceará State, Brazil. Acta Scientiae Veterinariae, v. 38, n. 3, 2010. FRÉZARD, F., DEMICHELI, C., RIBEIRO, R. R. Pentavalent antimonials: new perspectives for old drugs. Molecules, v. 14, n. 7, p. 2317-2336, 2009. FURONES, A. D., GALLEGO, F. C., ASENSI-DIEZ, R. Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis. Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, v. 41, n. 3, p. 433, 2017. GARCÍA, N., MORENO, I., ALVAREZ, J., DE LA CRUZ, M. L., NAVARRO, A., PÉREZSANCHO, M. Evidence of Leishmania infantum infection in rabbits (Oryctolagus cuniculus) in a natural area in Madrid, Spain. BioMed research international, v. 2014, 2014 GAZE, S. T., DUTRA, W. O., LESSA, M., LESSA, H., GUIMARAES, L. H., JESUS, A. R., CARVALHO, L. P., MACHADO, P., CARVALHO, E. M., GOLLOB, K. J. Mucosal leishmaniasis patients display an activated inflammatory T‐cell phenotype associated with a non balanced monocyte population. Scandinavian journal of immunology, v. 63, n. 1, p. 70- 78, 2006. GHALIB, H. W., PIUVEZAM, M. R., SKEIKY, Y. A., SIDDIG, M., HASHIM, F. A., ELHASSAN, A. M., REED, S. G. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. The Journal of clinical investigation, v. 92, n. 1, p. 324- 329, 1993. GHORBANI, M., FARHOUDI, R.Leishmaniasis in humans: drug or vaccine therapy?. Drug design, development and therapy, v. 12, p. 25, 2018. GIRGLA, H. S., MARSDEN, R. A., SINGH, G. M., RYAN, T. J. Post‐kala‐azar dermal leishmaniasis. British Journal of Dermatology, v. 97, n. 3, p. 307-311, 1977. GLANS, H., DOTEVALL, L., SÖBIRK, S. K., FÄRNERT, A., & BRADLEY, M. Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996–2016: a retrospective study of clinical characteristics, treatments and outcomes. BMC infectious diseases, v. 18, n. 1, p. 632, 2018. GOMES, R., OLIVEIRA, F., TEIXEIRA, C., MENESES, C., GILMORE, D. C., ELNAIEM, D. E., KAMHAWI, S., VALENZUELA, J. G. Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted Leishmania conferring ulcer-free protection. Journal of Investigative Dermatology, v. 132, n. 12, p. 2735-2743, 2012. GOTO, H., LINDOSO, J. A. L. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert review of anti-infective therapy, v. 8, n. 4, p. 419- 433, 2010. GOYAL, V., MAHAJAN, R., PANDEY, K., SINGH, S. N., SINGH, R. S., STRUBWOURGAFT, N., BALASEGARAM, M. Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India. PLoS neglected tropical diseases, v. 12, n. 10, p. e0006830, 2018. GOYAL, V., MAHAJAN, R., PANDEY, K., SINGH, S. N., SINGH, R. S., STRUBWOURGAFT, N., BALASEGARAM, M. Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India. PLoS neglected tropical diseases, v. 12, n. 10, p. e0006830, 2018. 59 GRADONI, L., Canine Leishmania vaccines: still a long way to go. Veterinary parasitology, v. 208, n. 1-2, p. 94-100, 2015. GRAMICCIA M., GRADONI, L. The current status of zoonotic leishmaniases and approaches to disease control. International journal for parasitology, v. 35, n. 11-12, p. 1169- 1180, 2005. H., GALVANI A.P., GAMBHIR M., GURARIE D., IRVINE M.A., JERVIS S., KEELING M.J., KELLY-HOPE L., KING C., LEE B.Y., LE RUTTE E.A, LIETMAN T.M., NDEFFOMBAH M., MEDLEY G.F., MICHAEL E. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasites & vectors, v. 8, n. 1, p. 630, 2015. HALL, B. S., BOT, C., WILKINSON, S. R. Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. Journal of Biological Chemistry, v. 286, n. 15, p. 13088-13095, 2011. HARMS G, SCHÖNIAN G, FELDMEIER H. Leishmaniasis in Germany. Emerging infectious diseases, v. 9, n. 7, p. 872, 2003. HASHIGUCHI, Y., GOMEZ, E. L., KATO, H., MARTINI, L.R., VELEZ, L.N., UEZATO, H. Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review. Tropical medicine and health, v. 44, n. 1, p. 2, 2016. HEJAZI, S., HOSEINI, S., JAVANMARD, S., ZARKESH, S., KHAMESIPOUR, A. Interleukin-10 and transforming growth factor-β in early and late lesions of patients with Leishmania major induced cutaneous leishmaniasis. Iranian journal of parasitology, v. 7, n. 2, p. 53, 2012. HEMMI, H., KAISHO, T., TAKEUCHI, O., SATO, S., SANJO, H., HOSHINO, K., AKIRA, S. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signalling pathway. Nature immunology, v. 3, n. 2, p. 196, 2002. HERRERO‐JÁUREGUI, C., CASADO, M. A., DAS GRAÇAS BICHARA ZOGHBI, M., CÉLIA MARTINS‐DA‐SILVA, R. Chemical variability of Copaifera reticulata Ducke oleoresin. Chemistry & biodiversity, v. 8, n. 4, p. 674-685, 2011. HOLLINGSWORTH T.D., ADAMS E.R., ANDERSON R.M., ATKINS K., BARTSCH S., BASÁÑEZ M., BEHREND M., BLOK D.J., CHAPMAN L.A.C., COFFENG L., COURTENAY O., CRUMP R.E., DE VLAS S.J, DOBSON A., DYSON L., FARKAS HUANG, X., XIAO, Y., KÖLLNER, T. G., ZHANG, W., WU, J., WU, J., ZHANG, Y. Identification and characterization of (E)-β-caryophyllene synthase and α/β-pinene synthase potentially involved in constitutive and herbivore-induced terpene formation in cotton. Plant physiology and biochemistry, v. 73, p. 302-308, 2013. INICIATIVA DE MEDICAMENTOS PARA DOENÇAS NEGLIGENCIADAS (DNDi). Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2. Disponivel em: https://clinicaltrials.gov/ct2/show/NCT01685827. Acesso em 10 de Março de 2019. INICIATIVA DE MEDICAMENTOS PARA DOENÇAS NEGLIGENCIADAS (DNDi). Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan. Disponivel em: https://clinicaltrials.gov/ct2/show/NCT01980199. Acesso em 10 de Março de 2019. 60 IZUMI, E., UEDA-NAKAMURA, T., DIAS FILHO, B. P., JÚNIOR, V. F. V., & NAKAMURA, C. V. Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Natural product reports, v. 28, n. 4, p.809- 823, 2011. JAMIL, K. M., HAQUE, R., RAHMAN, R., FAIZ, M. A., BHUIYAN, A. T. M. R. H., KUMAR, A., DESJEUX, P. Effectiveness study of paromomycin IM injection (PMIM) for the treatment of visceral leishmaniasis (VL) in Bangladesh. PLoS neglected tropical diseases, v. 9, n. 10, p. e0004118, 2015. JENNINGS, F. W.; URQUHART, G. M. The use of the 2 substituted 5-nitroimidazole, fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice. Zeitschrift für Parasitenkunde, v. 69, n. 5, p. 577-581, 1983. JHA S. N., SINGH N. K., JHA T. K. Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial. The Journal of the Association of Physicians of India, v. 39, n. 4, p. 314-316, 1991. JHA, T. K. Drug unresponsiveness & combination therapy for kala-azar. Indian Journal of Medical Research, v. 123, n. 3, p. 389, 2006. JOAS, J., VULCAIN, E., DESVIGNES, C., MORALES, E., LÉCHAUDEL, M. Physiological age at harvest regulates the variability in postharvest ripening, sensory and nutritional characteristics of mango (Mangifera indica L.) cv. Coghshall due to growing conditions. Journal of the Science of Food and Agriculture, v. 92, n. 6, p. 1282-1290, 2012. JOGLEKAR M.M., PANASKAR S.N., ARVINDEKAR A.U. Inhibition of advanced glycation end product formation by cymene—A common food constituent. J. Funct. Foods. V. 6, p. 107–115, 2014. JONES, K.E.; PATE, N.G.; LEVY, M.A.; STOREYGARD, A.; BALK, D.; GITTLEMAN, J.L.; DASZAK, F. Global trends in emerging infectious diseases. Nature, v. 451, n. 7181, p. 990, 2008. JUERGENS, U. R., DETHLEFSEN, U., STEINKAMP, G., GILLISSEN, A., REPGES, R., VETTER, H. Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respiratory medicine, v. 97, n. 3, p. 250-256, 2003. JUERGENS, U. R., STÖBER, M., SCHMIDT-SCHILLING, L., KLEUVER, T., VETTER, H. Antiinflammatory effects of euclyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo. European journal of medical research, v. 3, p. 407-412, 1998. KAISER, B., VOGG, G., FÜRST, U. B., & ALBERT, M. Parasitic plants of the genus Cuscuta and their interaction with susceptible and resistant host plants. Frontiers in plant science, v. 6, p. 45, 2015. KAISER, M., MÄSER, P., TADOORI, L. P., IOSET, J. R., & BRUN, R. Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. PLoS One, v. 10, n. 8, p. e0135556, 2015. KAMHAWI, S. Phlebotomine sand flies and Leishmania parasites: friends or foes?. Trends in parasitology, v. 22, n. 9, p. 439-445, 2006. KAMTE, S. L. N., RANJBARIAN, F., CIANFAGLIONE, K., SUT, S., DALL’ACQUA, S., BRUNO, M., HOFER, A. Identification of highly effective antitrypanosomal compounds in 61 essential oils from the Apiaceae family. Ecotoxicology and environmental safety, v.156, p. 154-165, 2018. KARAKUŞ, M., NASEREDDIN, A., ONAY, H., KARACA, E., ÖZKEKLIKÇI, A., JAFFE, C. L., KUHLS, K., ÖZBILGIN, A., ERTABAKLAR, H., DEMIR, S., ÖZBEL, Y., TÖZ S. Epidemiological analysis of Leishmania tropica strains and giemsa-stained smears from Syrian and Turkish leishmaniasis patients using multilocus microsatellite typing (MLMT). PLoS neglected tropical diseases, v. 11, n. 4, p. e0005538, 2017. KARTHIKEYAN, R., KANIMOZHI, G., PRASAD, N. R., AGILAN, B., GANESAN, M., & SRITHAR, G. Alpha pinene modulates UVA-induced oxidative stress, DNA damage and apoptosis in human skin epidermal keratinocytes. Life sciences, v. 212, p. 150-158, 2018. KEHRL, W., SONNEMANN, U., & DETHLEFSEN, U. Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double‐blind, randomized, placebo‐controlled trial. The Laryngoscope, v.114, n. 4, p.738-742, 2004. KENNEDY-FEITOSA, E., OKURO, R. T., RIBEIRO, V. P., LANZETTI, M., BARROSO, M. V., ZIN, W. A., VALENCA, S. S. Eucalyptol attenuates cigarette smoke-induced acute lung inflammation and oxidative stress in the mouse. Pulmonary pharmacology & therapeutics, v. 41, p. 11-18, 2016. KHAN, A., VAIBHAV, K., JAVED, H., TABASSUM, R., AHMED, M. E., KHAN, M. M., SAFHI, M. M. 1, 8-cineole (eucalyptol) mitigates inflammation in amyloid Beta toxicated PC12 cells: relevance to Alzheimer’s disease. Neurochemical research, v. 39, n.2, p. 344- 352, 2014. KIFER, D., , V., & , M. Š. Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1, 8-cineole against Staphylococcus aureus planktonic and biofilm growth. The Journal of antibiotics, v. 69, n. 9, p. 689, 2016. KIM, D. S., LEE, H. J., JEON, Y. D., HAN, Y. H., KEE, J. Y., KIM, H. J., KIM, S. J. Alphapinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-κB pathway in mouse peritoneal macrophages. The American journal of Chinese medicine, v. 43, n. 04, p. 731-742, 2015. KORDALI, S. , AHMET C., HAKAN O., RAMAZAN C., MEMIS K., EBRU M. Antifungal, Phytotoxic and Insecticidal Properties of Essential Oil Isolated from Turkish Origanum Acutidens and Its Three Components, Carvacrol, Thymol and P-Cymene. Bioresource Technology 99 (18). 2008. KOVAR K. A, GROPPER B., FRIESS D, AMMON H. P. T. Blood levels of 1, 8-cineole and locomotor activity of mice after inhalation and oral administration of rosemary oil. Planta Medica. V. 53, n.4, p. 315-18, 1987. KPOVIESSI, B. G. K., KPOVIESSI, S. D., LADEKAN, E. Y., GBAGUIDI, F., FRÉDÉRICH, M., MOUDACHIROU, M., BERO, J. In vitro antitrypanosomal and antiplasmodial activities of crude extracts and essential oils of Ocimum gratissimum Linn from Benin and influence of vegetative stage. Journal of ethnopharmacology, v. 155, n. 3, p. 1417-1423, 2014. KUMAR, R., BUMB, R. A., ANSARI, N. A., MEHTA, R. D., SALOTRA, P. Cutaneous leishmaniasis caused by Leishmania tropica in Bikaner, India: parasite identification and characterization using molecular and immunologic tools. The American journal of tropical medicine and hygiene, v. 76, n. 5, p. 896-901, 2007. 62 KUMARI, S., PUNDHIR, S., PRIYA, P., JEENA, G., PUNETHA, A., CHAWLA, K., YADAV, G. EssOilDB: a database of essential oils reflecting terpene composition and variability in the plant kingdom. Database (Oxford), v. 2014, 2014. KUMMER R., ESTEVÃO-SILVA C.F., BASTOS R.L., GRESPAN R., DE SOUZA SILVACOMAR F.M., SILVA E.L., SPIRONELLO R.A., ROCHA B.A., BERSANI-AMADO C.A., CUMAN R.K.N. Effect of p-cymene on chemotaxis, phagocytosis and leukocyte behaviors. Int. J. Appl. Res. Nat. Prod, v. 8, p. 20–27, 2015. LANA LEJ, DA SILVA RK, KOZHEVNIKOV IV, GUSEVSKAYA EV. Synthesis of 1, 8- cineole and 1,4-cineole by isomerisation of α-terpineol catalyzed by heteropoly acid. J. Mol. Catal. A Chem. v. 259, n. 1,p. 99-102, 2006. LEE, H. S., PARK, D. E., SONG, W. J., PARK, H. W., KANG, H. R., CHO, S. H., SOHN, S. W. Effect of 1.8-cineole in dermatophagoides pteronyssinus-stimulated bronchial epithelial cells and mouse model of asthma. Biological and Pharmaceutical Bulletin, v. 39, n. 6, p. 946-952, 2016. LEE, J.H., B.K. LEE, J.H. KIM, S.H. LEE AND S.K. HONG. Comparison of chemical compositions and antimicrobial activities of essential oils from three conifer trees; Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obusa. J. Microbiol. Biotechnol. 19: 391–396, 2009 LEHANE, M. J. The biology of blood-sucking in insects. Cambridge University Press, 2005. LEISHMAN, W. B. On the possibility of the occurrence of trypanosomiasis in India. British medical journal, v. 1, n. 2213, p. 1252, 1903. LEITNER, M., KAISER, R., RASMUSSEN, M. O., DRIGUEZ, H., BOLAND, W., MITHÖFER, A. Microbial oligosaccharides differentially induce volatiles and signalling components in Medicago truncatula. Phytochemistry, v. 69, n. 10, p. 2029-2040, 2008. LI, Y., XU, Y. L., LAI, Y. N., LIAO, S. H., LIU, N., & XU, P. P. Intranasal co-administration of 1, 8-cineole with influenza vaccine provide cross-protection against influenza virus infection. Phytomedicine, v. 34, p. 127-135, 2017. LIMA F.V., MALHEIROS A., OTUKI M.F., CALIXTO J.B., YUNES R.A., FILHO V.C., MONACHE F.D. Three new triterpenes from the resinous bark of Protium kleinii and their antinociceptive activity. Journal of the Brazilian Chemical Society, v. 16, n. 3B, p. 578- 582, 2005. LIMA, A. S., MILHOMEM, M. N., MONTEIRO, O. S., ARRUDA, A. C. P., DE CASTRO, J. A. M., FERNANDES, Y. M. L., COSTA-JUNIOR, L. M. Seasonal analysis and acaricidal activity of the thymol-type essential oil of Ocimum gratissimum and its major constituents against Rhipicephalus microplus (Acari: Ixodidae). Parasitology research, v. 117, n. 1, p. 59-65, 2018. LINDOSO, J. A. L., MOREIRA, C. H. V., CUNHA, M. A., & QUEIROZ, I. T. Visceral leishmaniasis and HIV coinfection: current perspectives. HIV/AIDS (Auckland, NZ), v. 10, p. 193, 2018. LOPES, V. V., BELO, V. S., PEREIRA, D. A., COELHO, M. B., PENA, H. P., ALVES, N. R., DA SILVA, E. S. IgG avidity index and complete blood count as biomarkers of clinical disease in naturally infected dogs with Leishmania infantum. Veterinary parasitology, v. 261, p. 96-103, 2018. 63 MACHADO, C. J. S., SILVA, E. G., VILANI, R. M. 2016. Use of an instrument of controversial public health policy: euthanasia of dogs contaminated by leishmaniasis in Brazil. Saúde e Sociedade, v. 25, n. 1, p. 247-258, 2016. MACHADO, P. R. L., PENNA, G. Miltefosine and cutaneous leishmaniasis. Current opinion in infectious diseases, v. 25, n. 2, p. 141-144, 2012. MACHADO, P. R., ROSA, M. E., COSTA, D., MIGNAC, M., SILVA, J. S., SCHRIEFER, A., TEIXEIRA, M. M., BACELLAR, O., CARVALHO, E. M. Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 105, n. 8, p. 438- 444, 2011. MAHMOUDVAND, H., DEZAKI, E. S., EZATPOUR, B., SHARIFI, I., KHEIRANDISH, F., & RASHIDIPOUR, M. In vitro and in vivo antileishmanial activities of Pistacia vera essential oil. Planta Medica, v. 82, n. 04, p. 279-284, 2016. MAIA C., L. CAMPINO. Can domestic cats be considered reservoir hosts of zoonotic leishmaniasis? Trends in parasitology, v. 27, n. 8, p. 341-344, 2011. MALAVIYA, P., PICADO, A., SINGH, S. P., HASKER, E., SINGH, R.P., BOELAERT, M., SUNDAR, S. Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. PLoS One, v. 6, n. 3, p. e14751, 2011. MAROLI, M., PENNISI, M. G., DI MUCCIO, T., KHOURY, C., GRADONI, L., & GRAMICCIA, M. Infection of sandflies by a cat naturally infected with Leishmania infantum. Veterinary parasitology, v. 145, n. 3-4, p. 357-360, 2007. MARQUES, S. M., CAMPOS, P. P., CASTRO, P. R., CARDOSO, C. C., ANDRADE, S. P. Genetic background determines mouse strain differences in inflammatory angiogenesis. Microvascular research, v. 82, n. 3, p. 246-252, 2011. MARSDEN, P. D. Letter from Brasilia: Mucocutaneous leishmaniasis. BMJ. British medical journal, v. 301, n. 6753, p. 656-657, 1990. MARTINDALE, W. H. Essential oil in relation to their antiseptic poweres. Purfum. Essent. Oil Rec., v. 1, p. 266-274, 1910. MATAN, NARUMOL; MATAN, NIRUNDORN; KETSA, SAICHOL. Enhanced inhibition of Aspergillus niger on sedge (L epironia articulata) treated with heat‐cured lime oil. Journal of applied microbiology, v. 115, n. 2, p. 376-381, 2013. MATEO, M., MAYNARD, L., VISCHER, C., BIANCIARDI, P., MIRÓ, G. Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis. Parasitology research, v. 105, n. 1, p. 155, 2009. MATHUR, R., DAS, R. P., RANJAN, A., SHAHA, C. (2015). Elevated ergosterol protects Leishmania parasites against antimony-generated stress. The FASEB Journal, v. 29, n. 10, p. 4201-4213, 2015. MATTIN, M.J., SOLANO-GALLEGO, L., DHOLLANDER, S., AFONSO, A., BRODBELT, D.C. The frequency and distribution of canine leishmaniosis diagnosed by veterinary practitioners in Europe. The Veterinary Journal, v. 200, n. 3, p. 410-419, 2014. 64 MCGWIRE B. S., SATOSKAR A. R. Leishmaniasis: clinical syndromes and treatment. QJM: An International Journal of Medicine, v. 107, n. 1, p. 7-14, 2013. MCGWIRE, B. S.; SATOSKAR, A. R. Leishmaniasis: clinical syndromes and treatment. QJM: An International Journal of Medicine, v. 107, n. 1, p. 7-14, 2013. MECHERGUI K., JAOUADI W., COELHO J. P., KHOUJA M. L. Effect of harvest year on production, chemical composition and antioxidant activities of essential oil of oregano (Origanum vulgare subsp glandulosum (Desf.) Ietswaart) growing in North Africa. Ind. Crops Prod, v. 90, p. 32–37, 2016. MELBY, P. C., ANDRADE-NARVAEZ, F. J., DARNELL, B. J., VALENCIA-PACHECO, G., TRYON, V. V., PALOMO-CETINA, A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infection and immunity, v. 62, n. 3, p. 837-842, 1994. MEYMANDI, S. S., JAVADI, A., DABIRI, S., MEYMANDI, M. S., NADJI, M. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy. Archives of Iranian Medicine (AIM), v. 14, n. 4, 2011 MILLÁN, J., FERROGLIO, E., SOLANO-GALLEGO, L., Role of wildlife in the epidemiology of Leishmania infantum infection in Europe. Parasitology research, v. 113, n. 6, p. 2005-2014, 2014. MINISTÉRIO DA SAÚDE. Ministério da Saúde, Ministério da Agricultura Pecuária e Abastecimento. Nota Técnica Conjunta n˚ 001/2016 MAPA/MS. 2016. Disponível em: http://www.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-devigilancia/doencas-de-transmissao-por-vetores-ezoonoses/doc/leish/lta_gve7ed_web_atual.pdf. Acessado em 31 Dezembro de 2018. MINISTÉRIO DA SAÚDE. Política Nacional de Plantas Medicinais e Fitoterápicos (PNPMF). 2016 . Disponível em: http://bvsms.saude.gov.br/bvs/publicacoes/politica_programa_nacional_plantas_medicinais_fi toterapicos.pdf. acesso em 06 de Fevereiro de 2019. MIRANDA-VERASTEGUI, C., TULLIANO, G., GYORKOS, T. W., CALDERON, W., RAHME, E., WARD, B., MATLASHEWSKI, G. First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. PLoS neglected tropical diseases, v. 3, n. 7, p. e491, 2009 MIRANDA-VERASTEGUI, C., TULLIANO, G., GYORKOS, T. W., CALDERON, W., RAHME, E., WARD, B., MATLASHEWSKI, G. First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. PLoS neglected tropical diseases, v. 3, n. 7, p. e491, 2009 MITROPOULOU G, FITSIOU E, STAVROPOULOU E, PAPAVASSILOPOULOU E, VAMVAKIAS M, PAPPA A, OREOPOULOU A, KOURKOUTAS Y. Composition, antimicrobial, antioxidant, and antiproliferative activity of Origanum dictamnus (dittany) essential oil. Microb Ecol Health Dis, v. 26, p. 26543, 2015; MORADIN, N., DESCOTEAUX, A. Leishmania promastigotes: building a safe niche within macrophages. Frontiers in cellular and infection microbiology, v. 2, p. 121, 2012. MORAES, C. S., AGUIAR-MARTINS, K., COSTA, S. G., BATES, P. A., DILLON, R. J., & GENTA, F. A. Second Blood Meal by Female Lutzomyia longipalpis: Enhancement by 65 Oviposition and Its Effects on Digestion, Longevity, and Leishmania Infection. BioMed research international, v. 2018, 2018. MUGNAINI L, NARDONI S, PISTELLI L, LEONARDI M, GIULIOTTI L, BENVENUTI MN, PISSERI F, MANCIANTI F. A herbal antifungal formulation of Thymus serpillum, Origanum vulgare and Rosmarinus officinalis for treating ovine dermatophytosis due to Trichophyton mentagrophytes. Mycoses. v. 56, n. 3, p. 333-7, 2013. MURRAY, H. W. Treatment of visceral leishmaniasis in 2004. The American journal of tropical medicine and hygiene, v. 71, n. 6, p. 787-794, 2004. MUSA, A. M., KHALIL, E. A., RAHEEM, M. A., ZIJLSTRA, E. E., IBRAHIM, M. E., ELHASSAN, I. M., MUKHTAR, M. M., EL HASSAN, A. M. The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic. Annals of Tropical Medicine & Parasitology, v. 96, n. 8, p. 765-772, 2002. MUSA, A., KHALIL, E., HAILU, A., OLOBO, J., BALASEGARAM, M., OMOLLO, R., ABUZAID, A. Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial. PLoS neglected tropical diseases, v. 6, n. 6, p. e1674, 2012 NABAVI, S. M. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. Food chemistry, v. 173, p. 339-347, 2015. NADJIB BOUKHATEM, M., KAMELI, A., AMINE FERHAT, M., SAIDI, F., & MEKARNIA, M. ROSE. Geranium essential oil as a source of new and safe antiinflammatory drugs. Libyan Journal of Medicine, v. 8, n. 1, p.22520, 2013. NELSON, D. J., BUGGE, C. J., ELION, G. B., BERENS, R. L., MARR, J. J. Metabolism of pyrazolo (3, 4-d) pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo (3, 4-d) pyrimidine. Journal of Biological Chemistry, v. 254, n. 10, p. 3959-3964, 1979. NEVES, L. O., TALHARI, A. C., GADELHA, E. P. N., JÚNIOR, S., GUERRA, J. A. D. O., FERREIRA, L. C. D. L., TALHARI, S. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis. Anais brasileiros de dermatologia, v. 86, n. 6, p. 1092-1101, 2011. NEWMAN, D. J., CRAGG, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of natural products, v. 75, n. 3, p. 311-335, 2012. NIKOLIĆ, B., VASILIJEVIĆ, B., MITIĆ-ĆULAFIĆ, D., VUKOVIĆ-GAČIĆ, B., & KNEŽEVIĆ-VUKĆEVIĆ, J. Comparative study of genotoxic, antigenotoxic and cytotoxic activities of monoterpenes camphor, eucalyptol and thujone in bacteria and mammalian cells. Chemico-biological interactions, v. 242, p. 263-271, 2015. NISSEN, L., ZATTA, A., STEFANINI, I., GRANDI, S., SGORBATI, B., BIAVATI, B., & MONTI, A. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). Fitoterapia, v. 81, n. 5, p. 413-419, 2010. NOLI, C., AUXILIA, S.T. Treatment of canine Old World visceral leishmaniasis: a systematic review. Veterinary dermatology, v. 16, n. 4, p. 213-232, 2005. NOVAIS, F. O., CARVALHO, L. P., PASSOS, S., ROOS, D. S., CARVALHO, E. M., SCOTT, P., BEITING, D. P. Genomic profiling of human Leishmania braziliensis lesions 66 identifies transcriptional modules associated with cutaneous immunopathology. Journal of Investigative Dermatology, v. 135, n. 1, p. 94-101, 2015. NOYES, H., PRATLONG, F., CHANCE, M., ELLIS, J., LANOTTE, G., & DEDET, J. A previously unclassified trypanosomatid responsible for human cutaneous lesions in Martinique (French West Indies) is the most divergent member of the genus Leishmania ss. Parasitology, v. 124, n. 1, p. 17-24, 2002. OLIVEIRA, F. A., VIEIRA-JÚNIOR, G. M., CHAVES, M. H., ALMEIDA, F. R., FLORÊNCIO, M. G., LIMA JR, R. C., RAO, V. S. Gastroprotective and anti-inflammatory effects of resin from Protium heptaphyllum in mice and rats. Pharmacological Research, v. 49, n. 2, p.105-111, 2004. OLIVEIRA, W. N., RIBEIRO, L. E., SCHRIEFFER, A., MACHADO, P., CARVALHO, E. M., BACELLAR, O. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis. Cytokine, v. 66, n. 2, p. 127-132, 2014. ORGANIZAÇÃO MUNDIAL DA Saúde (OMS). Control of the leishmaniasis: Report of the meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, Switzerland, 22-26 March 2010. Vol. 9492010, 2010. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/44412/WHO_TRS_949_eng.pdf;jsessionid=0 4946FDC751C40A2534524D4291ECFFA?sequence=1. Acesso em 20 Dezembro de 2018. ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Leishmanioses: Informe Epidemiológico das américas. 2018 Disponível em: http://iris.paho.org/xmlui/bitstream/handle/123456789/34857/LeishReport6_por.pdf?sequenc e=5. Acesso em: 2 de Dezembro de 2018. ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Weekly epidemiological record (WER). 2015. Disponível em: https://www.who.int/wer/2018/en/. Acesso: 20 de dezembro de 2018. ORTEGA, V., GIORGIO, S., DE PAULA, E. Liposomal formulations in the pharmacological treatment of leishmaniasis: A review. Journal of liposome research, v. 27, n. 3, p. 234-248, 2017. OWENS, S. D., OAKLEY, D. A., MARRYOTT, K., HATCHETT, W., WALTON, R., NOLAN, T. J., NEWTON, A., STEURER, F., SCHANTZ, P., GIGER, U. 2001. Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs. Journal of the American Veterinary Medical Association, v. 219, n. 8, p. 1076-1083, 2001. PAILA, Yamuna Devi; SAHA, Bhaskar; CHATTOPADHYAY, Amitabha. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochemical and biophysical research communications, v. 399, n. 3, p. 429-433, 2010. PALATNIK-DE-SOUSA, C. B. 2012. Vaccines for canine leishmaniasis. Frontiers in immunology, v. 3, p. 69, 2012. PALUMBO, E. Treatment strategies for mucocutaneous leishmaniasis. Journal of global infectious diseases, v. 2, n. 2, p. 147, 2010. PAN AMERICAN HEALTH ORGANIZATION (PAHO). Leishmaniasis: Epidemiological Report of the Americas: Washington; Pan American Health Organization. Disponível em: 67 http://iris.paho.org/xmlui/bitstream/handle/123456789/34856/LeishReport6_eng.pdf?sequenc e=1&isAllowed=y. Acesso em: 5 de Janeiro de 2018. PASSOS, S.R., RODRIGUES, T., DE, A., MADUREIRA, A.P., GIUNCHETTI, R.C., ZANINI, M.S. Clinical treatment of cutaneous leishmaniasis in dogs with furazolidone and domperidone. International journal of antimicrobial agents, v. 44, n. 5, p. 463-465, 2014. PAULA, C. D. R. D., SAMPAIO, J. H. D., CARDOSO, D. R., SAMPAIO, R. N. R. A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical, v. 36, n. 3, p. 365- 371, 2003. PAVLI, A., MALTEZOU, H. C. Leishmaniasis, an emerging infection in travelers. International Journal of Infectious Diseases, v. 14, n. 12, p. e1032-e1039, 2010. PEARSON, R. D., SOUSA, A. Q. Clinical spectrum of leishmaniasis. Clinical infectious diseases, p. 1-11, 1996. PECETTI, L., TAVA, A., ROMANI, M., CECOTTI, R., MELLA, M. Variation in terpene and linear‐chain hydrocarbon content in yarrow (Achillea millefolium l.) germplasm from the Rhaetian Alps, Italy. Chemistry & biodiversity, v. 9, n. 10, p.2282-2294, 2012. PEREIRA, L. I., DORTA, M. L., PEREIRA, A. J., BASTOS, R. P., OLIVEIRA, M. A., PINTO, S. A., GALDINO, H. JR., MAYRINK, W., BARCELOS, W., TOLEDO, V. P. Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens. The American journal of tropical medicine and hygiene, v. 81, n. 3, p. 378-383, 2009 PETERS, N. C., DEBRABANT, A., SACKS, D. L. Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response. PLoS pathogens, v. 8, n. 2, p. e1002536, 2012. PETERS, N. C., EGEN, J. G., SECUNDINO, N., DEBRABANT, A., KIMBLIN, N., KAMHAWI, S., LAWYER, P., FAY, M. P., GERMAIN, R. N., SACKS, D. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science, v. 321, n. 5891, p. 970-974, 2008. PIMENTA, P. F. P., SECUNDINO, N. F. C., BLANCO, E. E. N. Interação Leishmaniahospedeiro invertebrado. Flebotomíneos no Brasil. p. 275-289, 2003. POLI, A., SOZZI, S., GUIDI, G., BANDINELLI, P., MANCIANTI, F. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis. Veterinary parasitology, v. 71, n. 4, p. 263-271, 1997. POOT, J., JANSSEN, L.H., VAN KASTEREN-WESTERNENG, T.J., VAN DER HEIJDENLIEFKENS, K.H., SCHIJNS, V.E., HECKEROTH, A. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants. Vaccine, v. 27, n. 33, p. 4439-4446, 2009 PORRES-MARTÍNEZ, M., GONZÁLEZ-BURGOS, E., CARRETERO, M. E., & GÓMEZSERRANILLOS, M. P. In vitro neuroprotective potential of the monoterpenes α-pinene and 68 1, 8-cineole against H2O2-induced oxidative stress in PC12 cells. Zeitschrift für Naturforschung C, v. 71, n. 7-8, p. 191-199, 2016. PORRES-MARTÍNEZ, M., GONZÁLEZ-BURGOS, E., CARRETERO, M. E., GÓMEZSERRANILLOS, M. P. Major selected monoterpenes α-pinene and 1, 8-cineole found in Salvia lavandulifolia (Spanish sage) essential oil as regulators of cellular redox balance. Pharmaceutical biology, v. 53, n. 6, p. 921-929, 2015. RAETHER, W., HÄNEL, H. Nitroheterocyclic drugs with broad spectrum activity. Parasitology research, v. 90, n. 1, p. S19-S39, 2003. RAKHSHANPOUR, A., MALMASI, A., MOHEBALI, M., NABIAN, S., MIRHENDI, H., ZAREI, Z., AZARM, A. Transmission of leishmania infantum by rhipicephalus sanguineus (Acari: Ixodidae) in dogs. Iranian journal of parasitology, v. 12, n. 4, p. 482, 2017. RAKOTOMANGA, M.; SAINT-PIERRE-CHAZALET, M.; LOISEAU, P. M. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrobial agents and chemotherapy, v. 49, n. 7, p. 2677-2686, 2005. RAMESH, V., MUKHERJEE, A. Post‐kala‐azar dermal leishmaniasis. International journal of dermatology, v. 34, n. 2, p. 85-91, 1995. RAMESH, V., MUKHERJEE, A. Post‐kala‐azar dermal leishmaniasis. International journal of dermatology, v. 34, n. 2, p. 85-91, 1995. RANGEL, E. F., SOUZA, N. A., WERMELINGER, E. D., BARBOSA, A. F., ANDRADE, C. A. Biologia de Lutzomyia intermedia Lutz & Neiva, 1912 e Lutzomyia longypalpis Lutz & Neiva, 1912 (Diptera, Phychodidae), em condições experimentais. I. aspectos da alimentação de larvas e adultos. Memórias do Instituto Oswaldo Cruz, v. 81, n. 4, p. 431-438, 1986.. RAO V.S., MAIA J.L., OLIVEIRA F.A., LEMOS T.L.G., CHAVES M.H., SANTOS F.A. Composition and antinociceptive activity of the essential oil from Protium heptaphyllum resin. Natural Product Communications, v. 2, n. 12, p. 1199-1202, 2007. RATHER, M. A., DAR, B. A., DAR, M. Y., WANI, B. A., SHAH, W. A., BHAT, B. A., QURISHI, M. A. Chemical composition, antioxidant and antibacterial activities of the leaf essential oil of Juglans regia L. and its constituents. Phytomedicine, v. 19, n. 13, p. 1185- 1190, 2012. RATTANACHAIKUNSOPON, P., PHUMKHACHORN, P. Assessment of synergistic efficacy of carvacrol and cymene against Edwardsiella tarda in vitro and in Tilapia (Oreochromis niloticus). African Journal of Microbiology Research, v. 4, n. 5, p. 420-425, 2010. READY, P. D. Epidemiology of visceral leishmaniasis. Clinical epidemiology, v. 6, p. 147, 2014. REAL, F., FLORENTINO, P. T. V., REIS, L. C., RAMOS‐SANCHEZ, E. M., VERAS, P. S. T., GOTO, H., MORTARA, R. A. Cell‐to‐cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP‐rich parasitophorous extrusions. Cellular microbiology, v. 16, n. 10, p. 1549-1564, 2014RIBEIRO-GOMES, F. L., REARDON, A. J., ELLIOTT, J. A., & MCGANN, L. E. Investigating membrane and mitochondrial cryobiological responses of HUVEC using interrupted cooling protocols. Cryobiology, v. 71, n. 2, p. 306-317, 2015. 69 REGUERA, R. M., MORAN, M., PEREZ-PERTEJO, Y., GARCIA-ESTRADA, C., & BALANA-FOUCE, R. Current status on prevention and treatment of canine leishmaniasis. Veterinary parasitology, v. 227, p. 98-114, 2016. REIS, L. P., RUSCHEL, A. R., COELHO, A. A., DA LUZ, A. S., & MARTINS-DA-SILVA, R. C. V. Avaliação do potencial madeireiro na Floresta Nacional do Tapajós após 28 anos da exploração florestal. Pesquisa Florestal Brasileira, v. 30, n. 64, p. 265, 2010. RIBEIRO-SANTOS R., ANDRADE M., DE MELO N.R., DOS SANTOS F.R., DE ARAÚJO NEVES I., DE CARVALHO M.G., SANCHES-SILVA A. Biological activities and major components determination in essential oils intended for a biodegradable food packaging. Ind. Crops Prod., v. 97, p. 201–210, 2017. RIDLEY, D. S., DE MAGALHAES, A.V., MARSDEN, P. D. Histological analysis and the pathogenesis of mucocutaneous leishmaniasis. The Journal of pathology, v. 159, n. 4, p. 293-299, 1989. RIJAL, S., OSTYN, B., URANW, S., RAI, K., BHATTARAI, N. R., DORLO, T. P. C., BEIJNEN, J. H., VANAERSCHOT, M., DECUYPERE, S., DHAKAL, S. S., DAS, M. L., KARKI, P., SINGH, R., BOELAERT, M., DUJARDIN, J. C. Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clinical Infectious Diseases, v. 56, n. 11, p. 1530-1538, 2013. RITMEIJER, K., VEEKEN, H., MELAKU, Y., LEAL, G., AMSALU, R., SEAMAN, J., DAVIDSON, R. N. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Transactions of the Royal Society of Tropical Medicine and Hygiene, v. 95, n. 6, p. 668-672, 2001 RIVERA-YAÑEZ, C. R., TERRAZAS, L. I., JIMENEZ-ESTRADA, M., CAMPOS, J. E., FLORES-ORTIZ, C. M., HERNANDEZ, L. B., CANALES-MARTINEZ, M. M. AntiCandida Activity of Bursera morelensis Ramirez Essential Oil and Two Compounds, αPinene and γ-Terpinene—An In Vitro Study. Molecules, v. 22, n. 12, p. 2095, 2017. ROTUREAU, B., MORALES, M. A., BASTIN, P., SPÄTH, G. F. The flagellum– mitogen‐activated protein kinase connection in Trypanosomatids: a key sensory role in parasite signalling and development?. Cellular microbiology, v. 11, n. 5, p. 710-718, 2009. ROUSSEL, M., NACHER, M., FREMONT, G., ROTUREAU, B., CLYTI, E., SAINTEMARIE, D., COUPPIE, P. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Annals of Tropical Medicine & Parasitology, v. 100, n. 4, p. 307-314, 2006. SABATÉ, D., LLINÁS, J., HOMEDES, J., SUST, M., FERRER, L. A single-centre, openlabel, controlled, randomized clinical trial to assess the preventive efficacy of a domperidonebased treatment programme against clinical canine leishmaniasis in a high prevalence area. Preventive veterinary medicine, v. 115, n. 1-2, p. 56-63, 2014. SABZEVARI, S., RAZMI, G., NAGHIBI, A., KHOSHNEGAH, J. Serological study on visceral leishmaniasis in asymptomatic stray dogs in Mashhad, Iran. Archives of Razi Institute, v. 72, n. 4, p. 231-235, 2017 SABZEVARI, S., RAZMI, G., NAGHIBI, A., & KHOSHNEGAH, J. A molecular and SACKS, D., ANDERSON, C. Re‐examination of the immunosuppressive mechanisms mediating non‐cure of Leishmania infection in mice. Immunological reviews, v. 201, n. 1, p. 225-238, 2004SAHA, S., MONDAL, S., RAVINDRAN, R., BHOWMICK, S., MODAK, D., MALLICK, S., PRAMANIK, N. IL-10-and TGF-β-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. The Journal of Immunology, v. 179, n. 8, p. 5592-5603, 2007. SAMPATH, S., SUBRAMANI, S., JANARDHANAM, S., SUBRAMANI, P., YUVARAJ, A., CHELLAN, R. Bioactive compound 1, 8-Cineole selectively induces G2/M arrest in A431 cells through the upregulation of the p53 signaling pathway and molecular docking studies. Phytomedicine, 2018. SANTOS F. A, R. V. S. Antiinflammatory and antinociceptive effects of 1, 8-cineole a terpenoid oxide present in many plant essential oils. Phytother Res. v. 14, n. 4, p. 240-44, 2000. SANTOS FA, RAO VS. 1, 8-cineol, a food flavoring agent, prevents ethanol-induced gastric injury in rats. Dig. Dis. Sci, v.46, n.2, p. 331-7, 2001. SAPRA B, JAIN S, TIWARY AK. Percutaneous permeation enhancement by terpenes: mechanistic view. The AAPS journal, v. 10, n. 1, p. 120, 2008. SARAVOLATZ, L. D., BERN, C., ADLER-MOORE, J., BERENGUER, J., BOELAERT, M., DEN BOER, M., RITMEIJER, K. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clinical Infectious Diseases, v. 43, n. 7, p. 917-924, 2006. SAROUFIM, M., CHARAFEDDINE, K., ISSA, G., KHALIFEH, H., HABIB, R. H., BERRY, A., GHOSN, N., RADY, A., KHALIFEH, I. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerging infectious diseases, v. 20, n. 10, p. 1712, 2014. SATYAL, P., POWERS, C. N., PARDUCCI V, R., MCFEETERS, R. L., & SETZER, W. N. Chemical Composition, Enantiomeric Distribution, and Antifungal Activity of the Oleoresin Essential Oil of Protium amazonicum from Ecuador. Medicines, v. 4, n. 4, p.70, 2017. SCALAS, D., MANDRAS, N., ROANA, J., TARDUGNO, R., CUFFINI, A. M., GHISETTI, V., TULLIO, V. Use of Pinus sylvestris L.(Pinaceae), Origanum vulgare L.(Lamiaceae), and Thymus vulgaris L.(Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains. BMC complementary and alternative medicine, v. 18, n. 1, p. 143, 2018. SCHINK, A., NAUMOSKA, K., KITANOVSKI, Z., KAMPF, C. J., FRÖHLICHNOWOISKY, J., THINES, E., LUCAS, K. Anti-inflammatory effects of cinnamon extract and identification of active compounds influencing the TLR2 and TLR4 signaling pathways. Food & function, v. 9, n. 11, p. 5950-5964, (2018). SCHLEIN, Y., JACOBSON, R. L., MESSER, G. Leishmania infections damage the feeding mechanism of the sandfly vector and implement parasite transmission by bite. Proceedings of the National Academy of Sciences, v. 89, n. 20, p. 9944-9948, 1992. SCHUBACH, A., HADDAD, F., OLIVEIRA-NETO, M. P., DEGRAVE, W., PIRMEZ, C., GRIMALDI, G. JR., FERNANDES, O. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. Journal of Infectious Diseases, v. 178, n. 3, p. 911-914, 1998. SCHUBACH, A., MARZOCHI, M. C., CUZZI-MAYA, T., OLIVEIRA, A. V., ARAUJO, M. L., OLIVEIRA, A. L., PACHECO, R. S., MOMEN, H., CONCEICAO-SILVA, F., COUTINHO, S. G. Cutaneous scars in American tegumentary leishmaniasis patients: a site of 71 Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. The American journal of tropical medicine and hygiene, v. 58, n. 6, p. 824-827, 1998. SCORZA, BREANNA; CARVALHO, EDGAR; WILSON, MARY. Cutaneous manifestations of human and murine leishmaniasis. International journal of molecular sciences, v. 18, n. 6, p. 1296, 2017. SERAFIM, T. D., COUTINHO-ABREU, I. V., OLIVEIRA, F., MENESES, C., KAMHAWI, S., VALENZUELA, J. G. Sequential blood meals promote Leishmania replication and reverse metacyclogenesis augmenting vector infectivity. Nature microbiology, p. 1, 2018.. SERENO D., HOLZMULLER P., MANGOT I., CUNY G., OUAISSI A., LEMESRE J. Antimonial-Mediated DNA Fragmentation inLeishmania infantum Amastigotes. Antimicrobial agents and chemotherapy, v. 45, n. 7, p. 2064-2069, 2001. SHAKED-MISHAN, P., ULRICH, N., EPHROS, M., ZILBERSTEIN, D. Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. Journal of Biological Chemistry, v. 276, n. 6, p. 3971-3976, 2001. SHARIFI-RAD, J., SALEHI, B., SCHNITZLER, P., AYATOLLAHI, S. A., KOBARFARD, F., FATHI, M., SHARIFI-RAD, M. Susceptibility ofherpes simplex virus type 1 to monoterpenes thymol, carvacrol, p-cymene and essential oil sof Sinapis arvensisL., Lallemantia royleanaBenth. and Pulicaria vulgaris Gaertn. Cell Mol Biol (Noisy le Grand), v. 63, n. 8, 2017. SHARIFI-RAD, M., SALEHI, B., SHARIFI-RAD, J., SETZER, W. N., & IRITI, M. Pulicaria vulgaris Gaertn. essential oil: an alternative or complementary treatment for Leishmaniasis. Cellular and Molecular Biology, v. 64, n. 8, p. 18-21, 2018. SHAW, J. Ecological and evolutionary pressures on leishmanial parasites. Brazilian Journal of Genetics, v. 20, 1997. SHUKLA R, SINGH P, PRAKASH B, DUBEY NK. Antifungal, aflatoxin inhibition and antioxidant activity of Callistemon lanceolatus (Sm.) Sweet essential oil and its major component 1,8-cineole against fungal isolates from chickpea seeds. Food Control, v.25, n.1, p. 27-33, 2012. SIANI A.C., RAMOS M.F.S., DA MONTEIRO S.S., RIBEIRO-DOS-SANTOS R., SOARES R.O.A. Essential oils of the oleoresins from Protium Heptaphyllum growing in the Brazilian Southeastern and their cytotoxicity to neoplasic cells lines. Journal of Essential Oil Bearing Plants, v. 14, n. 3, p. 373-378, 2011. SIANI, A. C., MORAES, R., & JUNIOR, V. F. V. Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. Journal of Ethnopharmacology, v. 66, n. 1, p. 57-69, 1999. SIANI, A. C., RAMOS, M. D. S., MENEZES-DE-LIMA JR, O., RIBEIRO-DOS-SANTOS, R., FERNADEZ-FERREIRA, E., SOARES, R. O. A., HENRIQUES, M. D. G. Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. Journal of Ethnopharmacology, v. 66, n. 1, p. 57-69, 1999. SIANI, A. C.; RAMOS, M. F. S., SAMPAIO, A. L.; SOUZA, M. C.; HENRIQUES, M. G. M. O. Óleos essenciais: potencial antiinflamatório. 2000.SILVA, A. R., SCHER, R., SANTOS, F. V., FERREIRA, S. R., CAVALCANTI, S. C., CORREA, C. B., DOLABELLA, S. S. Leishmanicidal activity and structure-activity relationships of essential oil constituents. Molecules, v. 22, n. 5, p. 815, 2017. SILVA, F. L., OLIVEIRA, R. G., SILVA, T. M., XAVIER, M. N., NASCIMENTO, E. F., & SANTOS, R. L. Venereal transmission of canine visceral leishmaniasis. Veterinary parasitology, v. 160, n. 1-2, p. 55-59, 2009. SILVA, R. B. S., PORTO, M. L., BARBOSA, W. D. O., SOUZA, H. C. D., MARQUES, N. F. D. S. P., AZEVEDO, S. S., MELO, M. A. D. Seroprevalence and risk factors associated with canine visceral leishmaniasis in the State of Paraíba, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, v. 51, n. 5, p. 683-688, 2018. SINGH, G., DEY, C. S. Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani. Acta tropica, v. 103, n. 3, p. 172-185, 2007. SINGH, N., MISHRA, B. B., BAJPAI, S., SINGH, R. K., & TIWARI, V. K. Natural product based leads to fight against leishmaniasis. Bioorganic & Medicinal Chemistry, v. 22, n. 1, p. 18-45, 2014. SINGH, Nisha; KUMAR, Manish; SINGH, Rakesh Kumar. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pacific Journal of Tropical Medicine, v. 5, n. 6, p. 485-497, 2012. SMELCEROVIC, A., DJORDJEVIC, A., LAZAREVIC, J., & STOJANOVIC, G. (2013). Recent advances in analysis of essential oils. Current Analytical Chemistry, 9(1), 61-70. SOARES MCMS, DAMIANI CEN, MOREIRA CM, STEFANON I, VASSALLO DV. Eucalyptol, an essential oil, reduces contractile activity in rat cardiac muscle. Braz J Med Biol Res. 2005;38(3):453-61. SOLANO-GALLEGO L., RODR´IGUEZ-CORT´ES, A., INIESTA, QUINTANA L., PASTOR J., ESPADA J., ALBEROLA, J. Cross-sectional serosurvey of feline leishmaniasis in ecoregions around the Northwestern Mediterranean. The American journal of tropical medicine and hygiene, v. 76, n. 4, p. 676-680, 2007 SOUMYA, N., KUMAR, S. I. S. SHIVAPRASAD, L. N. GORAKH, N. DINESH, K. K. SWAMY, S. SINGH. AMP-acetyl CoA synthetase from Leishmania donovani: Identification and functional analysis of ‘PX4GK’motif. International journal of biological macromolecules, v. 75, p. 364-372, 2015. SOUMYA, N., PANARA, M. N., NEERUPUDI, K. B., & SINGH, S. Functional analysis of an AMP forming acetyl CoA synthetase from Leishmania donovani by gene overexpression and targeted gene disruption approaches. Parasitology international, 66(1), 992-1002, 2017. SOUZA, A. D., NUNES, V. L. B., BORRALHO, V. M., ISHIKAWA, E. A. Y. Domestic feline cutaneous leishmaniasis in the municipality of Ribas do Rio Pardo, Mato Grosso do Sul state, Brazil: a case report. Journal of Venomous Animals and Toxins including Tropical Diseases, v. 15, n. 2, p. 359-365, 2009. SOUZA, R. M. F., CARLOS, S. A., ROMERO,T. M. R., CAVALCANTE, G. A., LAHOZ DA SILVA, R. J. E. Essential oils from oleoresins of Protium spp. of the Amazon region. Flavour and fragrance journal, v. 15, n. 6, p. 383-387, 2000. 73 STEIGER, R. F. On the ultrastructure of Trypanosoma (Trypanozoon) brucei in the course of its life cycle and some related aspects. Acta tropica, v. 30, n. 1, p. 64, 1973. STIMPFL T., NAŠEL B., NAŠEL C., BINDER R., VYCUDILIK W., BUCHBAUER G. Concentration of 1, 8 cineole in blood during prolonged inhalation. Chemical Senses, v. 20, n.3, p. 349-50, 1995 STRAUSS-AYALI, D., BANETH, G., SHOR, S., OKANO, F., JAFFE, C. L. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs. International journal for parasitology, v. 35, n. 1, p. 63-73, 2005. SUNDAR S, MONDAL D, RIJAL, S., BHATTACHARYA, S., GHALIB, H., KROEGER, A., HARMS, G. Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal–the challenges for diagnosis and treatment. Tropical Medicine & International Health, v. 13, n. 1, p. 2-5, 2008. SUNDAR S., MORE D. K., SINGH M. K., SINGH, V. P., SHARMA, S., MAKHARIA, A., MURRAY, H. W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical infectious diseases, v. 31, n. 4, p. 1104- 1107, 2000. SUNDAR, S. AND CHAKRAVARTY, J. An update on pharmacotherapy for leishmaniasis. Expert opinion on pharmacotherapy, v. 16, n. 2, p. 237-252, 2015. SUNDAR, S., JHA, T. K., THAKUR, C. P., SINHA, P. K., BHATTACHARYA, S. K. Injectable paromomycin for visceral leishmaniasis in India. New England Journal of Medicine, v. 356, n. 25, p. 2571-2581, 2007. SUNDAR, S., MURRAY, H, W. Availability of miltefosine for the treatment of kala-azar in India. 2005. SUNDAR, S., SINGH, A. , RAI, M., PRAJAPATI, V. K., SINGH, A. K., OSTYN B., BOELAERT, M., DUJARDIN, J. C., CHAKRAVARTY J. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clinical Infectious Diseases, v. 55, n. 4, p. 543-550, 2012. SUNDAR, S., SINGH, A. Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology, v. 145, n. 4, p. 481-489, 2018. SUNDAR, S., SINGH, A. Recent developments and future prospects in the treatment of visceral leishmaniasis. Therapeutic advances in infectious disease, v. 3, n. 3-4, p. 98-109, 2016. SUNDAR, S., SINGH, A., TIWARI, A., SHUKLA, S., CHAKRAVARTY, J., RAI, M. Efficacy and safety of paromomycin in treatment of post-kala-azar dermal leishmaniasis. ISRN parasitology, v. 2014, 2014. SUNDAR, S., SINHA, P. K., RAI, M., VERMA, D. K., NAWIN, K., ALAM, S., CHAKRAVARTY, J., VAILLANT, M., VERMA, M., PANDEY, K., KUMARI, P., SHEKHAR LAL, S., ARORA, R., SHARMA, B., ELLIS, S., STRUB-WOURGAFT, N., BALASEGARAM M., OLLIARO, P., DAS, P., MODABBER, F. Comparison of shortcourse multidrug treatment with standard therapy for visceral leishmaniasis in India: an openlabel, non-inferiority, randomised controlled trial. The Lancet, v. 377, n. 9764, p. 477-486, 2011. 74 SUNDAR, S.; OLLIARO, P. L. Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Therapeutics and clinical risk management, v. 3, n. 5, p. 733, 2007. TACCHINI-COTTIER, F., WEINKOPFF, T., LAUNOIS, P. Does T helper differentiation correlate with resistance or susceptibility to infection with L. major? Some insights from the murine model. Frontiers in immunology, v. 3, p. 32, 2012. TAMARGO, B., MONZOTE, L., PIÑÓN, A., MACHÍN, L., GARCÍA, M., SCULL, R., & SETZER, W. N. In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis. Medicines, v. 4, n. 2, p. 38, 2017 TEIXEIRA, D. E., BENCHIMOL, M., RODRIGUES, J. C. F., CREPALDI, P. H., PIMENTA, P. F. P., DE SOUZA, W. Atlas didático: ciclo de vida da Leishmania. 1º ed. Rio de Janeiro: Fundação CECIERJ, Consórcio CEDERJ. 2013. E-book. THOMPSON, A., COOPER, J., INGRAM JR, L. L. Distribution of terpenes in heartwood and sapwood of loblolly pine. Forest products journal, v. 56, n. 7-8, p. 46-49, 2006. TOMAI, M. A., MILLER, R. L., LIPSON, K. E., KIEPER, W. C., ZARRAGA, I. E., & VASILAKOS, J. P. Resiquimod and other immune response modifiers as vaccine adjuvants. Expert review of vaccines, v. 6, n. 5, p. 835-847, 2007. TORREELE, E., TRUNZ, B. B., TWEATS, D., KAISER, M., BRUN, R., MAZUE, G., PECOUL, B. Fexinidazole–a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS neglected tropical diseases, v. 4, n. 12, p. e923, 2010. TORRES, M., BARDAGÍ, M., ROURA, X., ZANNA, G., RAVERA, I., FERRER, L. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. The veterinary journal, v. 188, n. 3, p. 346-351, 2011. TROTTA, T., FASANELLA, A., SCALTRITO, D., GRADONI, L., MITOLO, V., BRANDONISIO, O., ACQUAFREDDA, A., PANARO, M. A. 2010. Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability. Comparative immunology, microbiology and infectious diseases, v. 33, n. 2, p. 175-182, 2010. TUREK, C., STINTZING, F. C. Stability of essential oils: a review. Comprehensive Reviews in Food Science and Food Safety, v. 12, n. 1, p. 40-53, 2013. TURETZ, M. L., MACHADO, P. R., KO, A. I., ALVES, F., BITTENCOURT, A., ALMEIDA, R. P., MOBASHERY, N., JOHNSON, W. D. JR., CARVALHO, E. M. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. The Journal of infectious diseases, v. 186, n. 12, p. 1829-1834, 2002. TWEATS, D., BOURDIN T. B., TORREELE, E. Genotoxicity profile of fexinidazole—a drug candidate in clinical development for human African trypanomiasis (sleeping sickness). Mutagenesis, v. 27, n. 5, p. 523-532, 2012. U.S FOOD DRUG & DRUG ADMINISTRATION. CFR - Code of federal regulations title 21- chapter I--Food and Drug Ddministration. Department of health and human services. Subchapter B--food for human consumption (continued). Disponivel em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?FR=172.515. Acesso em 15 de Dezembro de 2018.UNITED NATIONS HIGH COMMISSIONER FOR REFUGEES. UNHCR country operations profile—Lebanon. 2014. Disponível em: http://www. unhcr.org/cgibin/texis/vtx/page?page=49e486676&submit=GO. Acesso em 20 de dezembro de 2018 URBINA, J. A. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology, v. 114, n. 7, p. 91-99, 1997. VAN GRIENSVEN, J., DIRO, E. Visceral leishmaniasis. Infectious Disease Clinics, v. 26, n. 2, p. 309-322, 2012. VAN ZANDBERGEN, G., KLINGER, M., MUELLER, A., DANNENBERG, S., GEBERT, A., SOLBACH, W., LASKAY, T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. The Journal of Immunology, v. 173, n. 11, p. 6521- 6525, 2004. VÉLEZ, I., LÓPEZ, L., SÁNCHEZ, X., LAUREANO, M., ROJAS, C., RODRÍGUEZ, E. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, v. 83, n. 2, p. 351-356, 2010. VERWEIJ, J., PLANTING, A., VAN DER BURG, M., STOTER, G. A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours. Journal of cancer research and clinical oncology, v. 118, n. 8, p. 606-608, 1992. VIANNA, G. Comunicação à Sessão de 24 de abril de 1912 da Sociedade Brasileira de Dermatologia. Arch Bras Med, v. 1, p. 36-38, 1912 VICTOR, V. M., & DE LA FUENTE, M. Changes in the superoxide production and other macrophage functions could be related to the mortality of mice with endotoxin-induced oxidative stress. Physiological research, v. 52, n. 1, p. 101-110, 2003. VIOL, M. A., GUERRERO, F. D., DE OLIVEIRA, B. C. M., DE AQUINO, M. C. C., LOIOLA, S. H., DE MELO, G. D., GOMES, A. H. S., KANAMURA, C. T., GARCIA, M. V., ANDREOTTI, R., LIMA, V. M. F., BRESCIANI K. D. S., DE LIMA, V. M. F. Identification of Leishmania spp. promastigotes in the intestines, ovaries, and salivary glands of Rhipicephalus sanguineus actively infesting dogs. Parasitology research, v. 115, n. 9, p. 3479-3484, 2016. VITORIANO-SOUZA, J., MOREIRA ND MENEZES-SOUZA, D., ROATT, B. M., DE OLIVEIRA AGUIAR-SOARES, R.D., SIQUEIRA-MATHIAS, F. A., DE OLIVEIRA CARDOSO, J. M., GIUNCHETTI, R. C., DE SÁ, R. G., CORRÊA-OLIVEIRA, R., CARNEIRO, C. M., REIS, A. B. Dogs immunized with LBSap vaccine displayed high levels of IL-12 and IL-10 cytokines and CCL4, CCL5 and CXCL8 chemokines in the dermis. Molecular immunology, v. 56, n. 4, p. 540-548, 2013. WAGNER, H., ULRICH-MERZENICH, G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine, v. 16, n. 2-3, p. 97-110, 2009. WANDERLEY, J. L. M., THORPE, P. E., BARCINSKI, M. A., & SOONG, L. Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function. Parasite immunology, v. 35, n. 3-4, p. 109-119, 2013. WANG, W., LI, N., LUO, M., ZU, Y., EFFERTH, T. Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules, v. 17, n. 3, 2012. 76 WASAN, E. K., GERSHKOVICH, P., ZHAO, J., ZHU, X., WERBOVETZ, K., TIDWELL, R. R., WASAN, K. M. A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model. PLoS neglected tropical diseases, v. 4, n. 12, p. e913, 2010. WASEEM, RABIA; LOW, KAH HIN. Advanced analytical techniques for the extraction and characterization of plant‐derived essential oils by gas chromatography with mass spectrometry. Journal of separation science, v. 38, n. 3, p. 483-501, 2015. WASUNNA, M., NJENGA, S., BALASEGARAM, M., ALEXANDER, N., OMOLLO, R., EDWARDS, T., KIRIGI, G. Efficacy and safety of AmBisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial. PLoS neglected tropical diseases, v. 10, n. 9, p. e0004880, 2016. WERNECK, G. L., COSTA, C. H., DE CARVALHO, F. A. A., E CRUZ, M. D. S. P., MAGUIRE, J. H., & CASTRO, M. C. Effectiveness of insecticide spraying and culling of dogs on the incidence of Leishmania infantum infection in humans: a cluster randomized trial in Teresina, Brazil. PLoS neglected tropical diseases, v. 8, n. 10, p. e3172, 2014. WINKELMANN, E.; RAETHER, W. New chemotherapeutically active nitroimidazoles. Curr Chemother Infect Dis. Proc 11th Int Congr Chemother, v. 2, p. 969-70, 1980. WIWANITKIT, V. Interest in paromomycin for the treatment of visceral leishmaniasis (kalaazar). Therapeutics and clinical risk management, v. 8, p. 323, 2012. WORTH, H., SCHACHER, C., DETHLEFSEN, U. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respiratory research, v.10, n.1, p.69, 2009. WYLLIE, S., CUNNINGHAM, M. L.; FAIRLAMB, A. H. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. Journal of Biological Chemistry, v. 279, n. 38, p. 39925-39932, 2004. WYLLIE, S., PATTERSON, S., STOJANOVSKI, L., SIMEONS, F. R., NORVAL, S., KIME, R., FAIRLAMB, A. H. The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis. Science translational medicine, v. 4, n. 119, p. 119re1- 119re1, 2012. XU, Q., LI, M., YANG, M., YANG, J., XIE, J., LU, X., CHEN, W. α-pinene regulates miR221 and induces G2/M phase cell cycle arrest in human hepatocellular carcinoma cells. Bioscience reports, v. 38, n. 6, p. BSR20180980, 2018. YADAV, N., CHANDRA, H. Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1, 8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFκB. PloS one, v. 12, n. 11, p. e0188232, 2017. YANG T. S., CHAO L. K., LIU T.T. J. Antimicrobial activity of the essential oil of Glossogyne tenuifolia against selected pathogens. Sci Food Agric. 2014 Nov; v. 94, n.14, p. 2965-71. YAO, C., & WILSON, M. E. Dynamics of sterol synthesis during development of Leishmania spp. parasites to their virulent form. Parasites & vectors, v. 9, n. 1, p. 200, 2016. YIMER M., ABERA B., MULU W., ZENEBE Y., BEZABIH B. Proportion of Visceral leishmaniasis and human immune deficiency virus co-infection among clinically confirmed visceral leishmaniasis patients at the endemic foci of the Amhara National Regional State, 77 north-west Ethiopia. American Journal of Biomedical and Life Sciences, v. 2, n. 1, p. 1-7, 2014. YU, N., SUN, Y. T., SU, X. M., HE, M., DAI, B., & KANG, J. Eucalyptol protects lungs against bacterial invasion through attenuating ciliated cell damage and suppressing MUC5AC expression. Journal of cellular physiology, v. 234, n. 5, p. 5842-5850, 2019. ZERPA, O., ULRICH, M., BLANCO, B., POLEGRE, M., AVILA, A., MATOS, N., MENDOZA, I., PRATLONG, F., RAVEL, C., CONVIT, J. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. British journal of Dermatology, v. 156, n. 6, p. 1328-1335, 2007. ZHAO, Y, Chen R., Wang Y., Yang . α-Pinene inhibits human prostate cancer growth in a mouse xenograft model. Chemotherapy, v. 63, n. 1, p. 1-7, 2018. ZHONG, Weiting et al. p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation. Inflammation, v. 36, n. 3, p. 529-537, 2013. ZHOU, J. Y., WANG, X. F., TANG, F. D., ZHOU, J. Y., LU, G. H., WANG, Y., BIAN, R. L. Inhibitory effect of 1, 8‐cineol (eucalyptol) on Egr‐1 expression in lipopolysaccharide‐stimulated THP‐1 cells 1. Acta pharmacologica sinica, v. 28, n.6, p.908- 912, 2007. ZIJLSTRA, E. E., MUSA, A. M., KHALIL, E. A., EL-HASSAN, I.M., EL-HASSAN, A. M. Post-kala-azar dermal leishmaniasis. The Lancet infectious diseases, v. 3, n. 2, p. 87-98, 2003. ZORAN K, IVICA A, IVANA M, GORANKA PM, SONJA PR, TEUTA M. Antibacterial Activity of Halothane, Eucalyptol and Orange Oil. Acta Stomatol Croat. 2000;34(3):307-9. | por |
dc.subject.cnpq | Medicina Veterinária | por |
dc.subject.cnpq | Parasitologia | por |
dc.subject.cnpq | Microbiologia | por |
dc.thumbnail.url | https://tede.ufrrj.br/retrieve/68696/2019%20-%20Raissa%20Couto%20Santana.pdf.jpg | * |
dc.originais.uri | https://tede.ufrrj.br/jspui/handle/jspui/5504 | |
dc.originais.provenance | Submitted by Leticia Schettini (leticia@ufrrj.br) on 2022-03-31T16:57:45Z No. of bitstreams: 1 2019 - Raissa Couto Santana.pdf: 2065280 bytes, checksum: 1266e59f21dbdf6ff5ea36517618a374 (MD5) | eng |
dc.originais.provenance | Made available in DSpace on 2022-03-31T16:57:45Z (GMT). No. of bitstreams: 1 2019 - Raissa Couto Santana.pdf: 2065280 bytes, checksum: 1266e59f21dbdf6ff5ea36517618a374 (MD5) Previous issue date: 2019-02-25 | eng |
Appears in Collections: | Mestrado em Ciências Veterinárias |
Se for cadastrado no RIMA, poderá receber informações por email.
Se ainda não tem uma conta, cadastre-se aqui!
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2019 - Raissa Couto Santana.pdf | 2019 - Raissa Couto Santana | 2.02 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.